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Cellular proteins are synthesized by ribosomes, which are ~3 MDa 
macromolecular complexes comprised of four ribosomal RNAs and ~80 
ribosomal proteins in yeast. The biogenesis of such complicated 
ribonucleoprotein complexes is a highly regulated, multistep process requiring 
a plethora of more than 200 unique assembly factors. Energy-harnessing 
enzymes, such as ATPases and GTPases, are needed to remodel the 
precursors of ribosomes at fast time scales. Mdn1 is an essential dynein-like 
AAA protein (ATPases Associated with various Activities) that releases specific 
assembly factors from the precursors of 60S subunit of ribosomes. However, 
Mdn1’s unusually large size (~5000 amino acids in a single polypeptide) and 
the transient nature of intermediates of ribosome biogenesis have limited our 
understanding how Mdn1 remodels pre-60S particles. In addition, the limited 
homology of Mdn1 to other well-studied proteins, including dyneins, has 
restricted our understanding of its function. Here, I first combined chemical and 
biochemical approaches to develop and validate ribozinoindoles (Rbins) as the 
cell-permeable inhibitors of Mdn1, which are the first potent and selective 
inhibitors of ribosome biogenesis in eukaryotes. These compounds can be 
further used to dissect the dynamic functions of Mdn1 during the multistep 
process of ribosome biogenesis. In addition, I solved three cryo-EM structures 
of both full-length and truncated Mdn1 (resolution up to 4.0 Å) that provided the 
first pseudo-atomic models for Mdn1 in two distinct nucleotide states. 
Remarkably, Mdn1’s the C-terminal MIDAS domain (Metal Ion-Dependent 
Adhesion Site), which interacts with other ribosome assembly factors, docks 
onto the N-terminal AAA ring in a nucleotide state-specific manner, even though 
they are separated by more than 2000 aa. These data suggest that 
conformational changes in the AAA ring can be directly transmitted to the 
MIDAS domain, thereby driving the selective release of the MIDAS-bound 
assembly factors from the precursors of 60S subunit of ribosomes. Together, 
these chemical biology, biochemical and structural studies of Mdn1 reveal how 
an AAA protein can contribute to the dynamic ribosome biogenesis process in 
eukaryotes. 
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1.1 Overview of ribosome biogenesis 
All cellular proteins are synthesized by ribosomes, which are >3 MDa 
macromolecular complexes comprised of four ribosomal RNAs (rRNA) and 
~80 ribosomal proteins in yeast (Yusupova and Yusupov, 2014). These 
complex nanomachines consist of two ribonucleoprotein subunits, the large 
60S subunit (LSU) and the small 40S subunit (SSU). The 60S subunit contains 
three rRNAs (25S, 5.8S and 5S) and 46 ribosomal proteins while the 40S 
subunit is comprised of one rRNA (18S) and 33 different ribosomal proteins. 
The 60S subunit possesses the peptidyl transfer center and the peptide exit 
tunnel while the 40S subunit functions as the decoding center to proofread the 
complementary interaction between messenger RNAs (mRNA) and transfer 
RNAs (tRNA).  
In rapidly dividing cells, a substantial fraction of essential cellular 
pathways, including transcription, translation and nuclear transport, are 
dedicated to producing required numbers of these complex macromolecular 
machines for growth (Thomson et al., 2013; Tschochner and Hurt, 2003; 
Warner, 1999). For instance, every minute a growing budding yeast cell has to 
generate ~2000 ribosomes to double the number of ribosomes during the ~90 
minutes doubling time (Warner, 1999). To ensure the translation-competency 
of the final products, ribosome biogenesis is a highly regulated and multi-step 
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process requiring a plethora of more than 200 unique assembly factors. 
Consistent with the vital roles of translational fidelity in cells, defects in 
ribosome assembly are linked to various human diseases referred to as 
ribosomopathies or could be embryonically lethal (Freed et al., 2010). 
Currently, understanding the molecular mechanism of these phenotypes is 
challenging, as the functional roles of different assembly factors remain poorly 
understood.  
Ribosome biogenesis begins from the transcription of ribosomal DNA 
(rDNA) in the nucleolus to generate the 35S pre-rRNA that includes the 
mature 18S, 5.8S and 25 S rRNA sequences from 5’ to 3’, divided by two 
internal transcribed spacers (ITS1 and ITS2) (Figure 1-1A) (Konikkat and 
Woolford, 2017). The modification and processing of the pre-rRNA are 
coupled to ordered association and dissociation of different ribosomal proteins 
and assembly factors to form various intermediates in the nucleus (Figure 1-
1B) (Kressler et al., 2012). The first stable pre-ribosome intermediate, 
composed of the emerging pre-rRNA and ~70 assembly factors, were directly 
visualized by electron microscopy as knobs on rDNA chromatin spreads, 
suggesting the assembling process can be co-transcriptional, likely starting 
from the 5’ end of the pre-rRNA (Miller and Beatty, 1969). These intermediates 
were found to represent the co-transcriptionally assembled precursors of the 
40S subunit (also named as SSU processome or 90S particle) (Grandi et al., 
2002).  Recent cryo-EM structures of the SSU processome reveal that the 
rRNA domains at the 5’ end of the precursors of 18S rRNA transcript adopt 
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conformations similar to those in the mature 40S subunit while domains in the 
3’ end are distinctly different, indicating a hierarchical, 5’-to-3’-oriented 
assembly process (Chaker-Margot et al., 2017; Kornprobst et al., 2016; Sun et 
al., 2017).  
Figure 1-1. Overview of ribosome biogenesis in eukaryotes. (A) 
Schematics for the pre-RNAs and the composition of rRNA in mature 
ribosomes. The segments of rRNA in mature ribosomes and the internal 
transcribed spacers (ITS1 and ITS2) are labeled. (B) Ribosome biogenesis 
starts with the transcription of rDNA in the nucleolus. Processing and 
remodeling of precursors of 60S and 40S subunits (pre-60S and pre-40S) are 
separated in the nucleolus, nucleoplasm and cytoplasm. The matured 60S and 
40S subunits combine in the cytoplasm to form the functional ribosome.  
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Cleavage of ITS1 leads to separation of the rRNA transcripts of the 60S 
subunit from that of the 40S subunit (Figure 1-1A), also marking the point after 
which the two subunits are assembled largely independently from each other 
(Tschochner and Hurt, 2003; Woolford and Baserga, 2013). Properly 
assembled precursors of 60S and 40S subunits are then exported to the 
cytoplasm, where the final remodeling steps lead to functional ribosomes 
(Figure 1-1B).  
In contrast to the relatively straightforward 5’-to-3’ sequential folding of 
the 18S rRNA in the 40S subunit, assembly of the 60S subunit appears more 
complex as the six conserved rRNA domains of 25S and 5.8S rRNA are 
intertwined with the ribosomal proteins in the mature ribosome (Klinge et al., 
2011). The folding and interaction of rRNA are assisted by specific assembly 
factors under tight spatiotemporal regulation, producing multiple intermediates 
collectively referred to as pre-60S particles. Identification of different assembly 
factors involved at different stages of ribosome biogenesis and the 
implementation of affinity-purification approaches led to the purification of 
specific pre-60S particles (Nissan et al., 2002). Their molecular compositions 
were defined through RNA analyses by northern blots and protein analyses by 
mass spectrometry. The rRNA processing events can thus be correlated with 
the association and dissociation of specific sets of assembly factors. While the 
overall reaction pathway is known, the molecular mechanism of the RNA 
processing and the functions of the assembly factors remain outstanding 
questions in the field of ribosome biogenesis. 
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 Recent progress in cryo-EM allowed the visualization of key pre-60S 
particles at atomic or near-atomic resolution, providing not only insights into 
the processing and folding process of the rRNA but also the structural 
framework for the functional analysis of assembly factors (Konikkat and 
Woolford, 2017). These particles include multiple states of Nsa1 associated 
pre-60S particles in the nucleolus, the early nucleoplasmic Nog2 particles and 
the late nucleoplasmic Rix1 particles, and the cytoplasmic Nmd3 particle. The 
insights from these structural studies into the ordered assembling of 
ribosomes are briefly summarized below. 
Comparisons of high-resolution structures of different nucleolar pre-
ribosomes isolated by pulldown of tagged Nsa1 and the early nucleoplasmic 
Nog2 particle suggest that individual rRNA domains in pre-60S particles are 
assembled in a modular manner (Kater et al., 2017; Sanghai et al., 2018; Wu 
et al., 2016). In particular, domains I and II of 25S rRNA, which constructs the 
solvent-exposed side of the 60S subunits, already folds into its mature 
conformation in the earliest Nsa1-containing pre-60S particle, suggesting they 
function as a scaffold for further construction. In addition, Nsa1-associated 
intermediates with either rRNA domain III or domain VI folded are observed, 
likely representing two different pathways to generate a converging 
intermediate in which these two domains are later joined by domain IV as 
observed in the nucleoplasmic Nog2 particle. The stepwise construction of 
different rRNA domains is accompanied by the formation of the peptide exit 
tunnel that is surrounded by these rRNA domains.   
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In the nucleolar pre-60S particles, Nsa1 is associated with a group of 
known early factors, including Rpf1 that functions as a placeholder for the pre-
matured PET (Kater et al., 2017). The removal of Nsa1 and its tightly 
associated proteins from the nucleolar pre-60S particle, most likely driven by 
an AAA protein (ATPase Associated with various Activities), Rix7, would result 
in an empty pre-PET (Kressler et al., 2008). This empty pre-PET can be 
probed by other nucleoplasmic factors in a later pre-60S particle, such as 
Nog1 in the nucleoplasmic Nog2 particle, as an additional quality control step 
to ensure the generation of properly assembled PET (Wu et al., 2016). 
Another evident difference between the nucleolar particles and the Nog2 
particle is the absence of Ytm1-Erb1 subcomplex in the later. In the Nsa1 
particles, the Ytm1-Erb1 subcomplex and its associated proteins covers the 
ITS2 site of the rRNA that separates the 25S and 5.8S rRNA transcripts (See 
Figure 1-1A) (Kater et al., 2017; Sanghai et al., 2018). The release of Ytm1-
Erb1 and its associated assembly factors are required for the recruitment of 
the nuclease Las1 to cleave the ITS2 site (Gasse et al., 2015). In addition, the 
binding site of Ytm1-Erb1 overlaps with where Nop53 binds in the Nog2 
particle, which is an adaptor protein that recruits the exosome to further 
process the cleaved ITS2 (Wu et al., 2016). Therefore, proper removal of 
Ytm1-Erb1 subcomplex is a required for further irreversible cleavage and 
processing of rRNAs. Previous yeast two-hybrid experiments revealed that 
Ytm1 could directly interact with the MIDAS domain (Metal Ion Dependent 
Adhesion Site) in Mdn1, which is the largest AAA protein in eukaryotes (~5000 
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amino acids in a single polypeptide chain) (Bassler et al., 2010). Disruption of 
this interaction leads to retention of nucleolar assembly factors in later 
nucleoplasmic pre-60S particles and accumulation of rRNA intermediates with 
uncleaved ITS2, suggesting that this interaction is required for the removal of 
nucleolar factors and processing of ITS2. At last, the Nog2 particle, but none 
of the Nsa1-associated pre-60S particles, contains the 5S RNP 
(ribonucleoprotein), assembled separately by the 5S rRNA, Rpl5 and Rpl11. 
However, this 5S RNP is oriented ~180°-rotated compared to its position in the 
mature ribosome. These comparisons reveal the timing of assembly of 5S 
RNP and also suggest that its additional remodeling is required. 
The structure of Rix1 particle revealed features of late nucleoplasmic 
pre-ribosomes before the nuclear export (Barrio-Garcia et al., 2016). In 
comparison to the Nog2 particle, the 5S RNP is rotated by ~180° in the Rix1 
particle, forming the basis of central protuberance close to its mature 
conformation. The Rpf2-Rrs1 subcomplex that anchors the 5S RNP in its 
immature conformation in the Nog2 particle is absent in the Rix1 particle. 
Instead, additional factors, including the Rix1 subcomplex and its interactor 
Mdn1, are recruited to regions that would clash with the Rpf2-Rrs1 
subcomplex if it was retained, suggesting the binding of these later assembly 
factors are coupled to the repositioning of 5S RNP. Interestingly, Mdn1’s 
MIDAS domain also interacts with another assembly factor Rsa4, and this 
interaction is required for the ATP-dependent release of Rsa4 from the Rix1 
particle and relocation of helix structures of rRNA in the peptidyl transfer 
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center (Bassler et al., 2014; Ulbrich et al., 2009). This energy-dependent 
remodeling process by Mdn1 appears to be the key irreversible, proofreading 
step to ensure that only pre-ribosomes with properly oriented 5S RNP could 
be further processed for the maturation of peptidyl transfer center. In addition, 
the Mdn1 remodeling step also triggers hydrolysis of GTPase Nog2 and its 
release, so that Nmd3, the adaptor protein that recruits the nuclear exportin 
Crm1, can bind to the site previously occupied by Nog2 in the nucleoplasmic 
pre-60S particles (Matsuo et al., 2014). 
 A recent structure of Nmd3 particle provides structural insights into the 
cytoplasmic maturation process of pre-ribosomes (Ma et al., 2017). In 
particular, the Nmd3 interacts with the peptidyl transfer center in its near-
mature conformation, suggesting the proofreading function of Nmd3. In 
addition, the Nog1 is removed, most likely promoted by another AAA protein 
Drg1 (Kappel et al., 2012; Lo et al., 2010), leaving the peptide exit tunnel 
available for Reh1. The C-terminal helix of Reh1 is inserted into the PET in the 
Nmd3 particle, functioning as another placeholder to check the structural 
integrity of this functional site. 
In summary, previous biochemical and structural studies of pre-
ribosomes revealed three common themes for the function of assembly factors 
in ribosome biogenesis: (i) the exploitation of steric hindrance and molecular 
mimicry of assembly factors or ribosomal proteins to block pre-matured 
binding of later factors (Sanghai et al., 2018); (ii) the reoccurring quality 
controls coupled to the complementary interaction between the assembly 
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factors and intermediate functional sites; (iii) the multiple involvements of 
energy-harnessing enzymes, in particular AAA proteins, for the irreversible 
removal of assembly factors as key remodeling events. However, how these 
AAA proteins perform their mechanical functions in cells remains poorly 
understood due to the transient nature of these remodeling steps in ribosome 
biogenesis. 
1.2  Overview of AAA proteins 
The AAA protein family is a large and functionally diverse group of 
enzymes that can couple ATP-hydrolysis with mechanical work (Erzberger and 
Berger, 2006; Hanson and Whiteheart, 2005). AAA proteins are required for 
different essential cellular processes, such as protein homeostasis, molecular 
transport and DNA replication, as well as ribosome biogenesis. Exactly how 
different AAA proteins contribute to diverse cellular pathways has remained 
largely an open question and been actively studied. 
The hallmark of the AAA proteins is a ~250 amino acids AAA domain 
comprised of a large and a small subdomains, which usually oligomerize to 
form the functional enzymes (Erzberger and Berger, 2006). The ATPase sites 
in AAA proteins lie at the interface between two neighboring AAA domains 
within the functional oligomers. During the ATPase cycle, the nucleotide state 
of the ATPase site can be recognized by the neighboring AAA domains or 
subdomains. Alterations of the nucleotide state can drive the change of the 
relative orientation of surrounding AAA domains or subdomains, thus the 
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overall conformation of the oligomers and apply mechanical force to their 
cellular substrates. As AAA proteins are involved in different cellular pathways, 
the force generated is applied to a large array of client proteins, including other 
soluble/membrane proteins with specific signaling peptide or biophysical 
properties, DNA double helix, cytoskeleton filaments or pre-ribosomes. During 
evolution, different AAA proteins are tailored based on the specific mechanical 
tasks for the corresponding client proteins, leading to diverse 
mechanochemical mechanisms among different members of the superfamily. 
 The “classic clade” of AAA family includes a group of extensively 
studied AAA proteins, such as ClpX, Yme1 and P97 (Erzberger and Berger, 
2006). These AAA proteins can recognize either unstructured or misfolded 
peptide sequence and unfold their client proteins, therefore they are also 
called as AAA unfoldases. Biochemical and structural studies reveal that they 
all function as homohexamers of six identical polypeptide chains that 
assemble into a ring-like structure (Figure 1-2). Both ClpX and Yme1 have one 
AAA domain in a single polypeptide and function by forming hexameric AAA 
rings while P97 has two AAA domains therefore forms a double-layered ring 
structure (Figure 1-2B). In these AAA unfoldases, conserved ‘Ar-Φ-Gly’ 
tripeptide (Ar: aromatic residue; Φ: hydrophobic residue, named ‘pore loop’) 
from each AAA domain interacts with the client proteins inside the central hole 
of the AAA ring (Bodnar and Rapoport, 2017; Martin et al., 2008; Puchades et 
al., 2017). During ATP hydrolysis, the conformational changes of the AAA 
domains can drive the movement of pore loops and thread their substrates 
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through the central hole processively (Figure 1-2B). Interestingly, Rix7 and 
Drg1, the two AAA proteins required for the removal of Nsa1 and Rpl24 from 
the nucleolar and cytoplasmic pre-60S particles, respectively, are highly 
homologous to P97 (Kressler et al., 2012) and have the conserved ‘Ar-Φ-Gly’ 
tripeptide in their orthologs. It is likely that Rix7 and Drg1 recognize exposed 
sequence of Nsa1 and Rpl24, respectively, and extract them out from the 
corresponding pre-60S particles during ATPase cycle similar to other AAA 
unfoldases. 
Figure 1-2. Domain organizations and schematics for the functional 
hexamers of ClpX and P97. (A) Domain organizations of ClpX and P97 and 
(B) schematics of their homohexamers are shown. The conserved pore loops 
(red curves) are highlighted in (B).  
 Another extensively studied AAA protein is dynein, the molecular motor 
that can transport cargos along microtubules during ATP hydrolysis (Schmidt 
and Carter, 2016). The force-generation properties of different dynein isoforms 
have been implicated to play important roles in cell division, intraflagellar 
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transport, signaling and cilia beatings. Particular cellular functions have been 
linked to diverse N-terminal sequences from different dyneins, which acts as a 
cargo-binding domain targeting different isoforms to the corresponding 
substrates (Figure 1-3A). On the other hand, the C-terminal sequence (~3500 
amino acids) forms a relatively conversed AAA motor domain, an engine that 
transforms the chemical energy stored in ATP into directional movement. An 
unusual feature of the motor domain is that six non-equivalent AAA domains 
are linked in a single polypeptide chain, forming a pseudo-hexameric AAA ring 
(Figure 1-3B). This asymmetry leads to functional specializations of individual 
AAA domains: (i) The AAA1 site is the “main” site for ATP hydrolysis that 
drives the conformational changes of dynein and AAA3, also being competent 
in ATP hydrolysis, acts as a regulatory switch to control the overall activities of 
AAA1. The AAA2 and AAA4 do not possess conserved key motifs required for 
hydrolysis. The AAA5 and AAA6 have highly degenerate sequences lacking 
motifs for both ATP binding and hydrolysis, suggesting these four sites play 
structural, instead of enzymatic, roles. (ii) The sequence immediately before 
AAA1 forms multiple helical bundles and connects to the N-terminal domains 
that appear as a protrusion from the AAA ring. (iii) Structural studies revealed 
that a long insertion in AAA4 domain forms an elongated “stalk” extending ~20 
nm out of the AAA ring. The microtubule-binding domain (MTBD) lies at the tip 
of the stalk.  
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Figure 1-3. Domain organization and structure of D. discoideum dynein 
and S. pombe Mdn1. (A) Domain organization (aa 1-4730) and (B) structural 
model of D. discoideum dynein (PDB: 3VKH). Different domains are colored 
based on (A). A schematic of the model is also shown on the right. The N-
terminal sequence and microtubule-binding domain (MTBD) not observed in 
the crystal structure are marked as dashed lines. (C) Domain organization of 
S. pombe Mdn1 (aa 1-4717). Note the linker domain in Mdn1 and the linker 
domain in dynein have the same name for historical reasons but otherwise not 
related to each other. 
Our current model for how dynein performs its mechanical functions is 
largely based on recent single-molecular and high-resolution structural 
analyses of cytoplasmic dyneins from different species (Bhabha et al., 2014; 
DeWitt et al., 2015; Kon et al., 2012; Reck-Peterson et al., 2006). During ATP 
hydrolysis in AAA1, the opening and closing of the AAA1 ATPase site are 
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coupled to the conformational changes of the microtubule-binding domain 
through the stalk, leading to binding or unbinding to microtubules and also 
drive the bending of the linker domain, applying force to its cargoes that are 
associated with the N-terminal sequence of dynein (See domain organization 
in Figure 1-3B). 
Interestingly, Mdn1, the AAA protein that remodels both nucleolar and 
nucleoplasmic pre-60S particle, also has six non-equivalent AAA domains 
linked in a single polypeptide chain (domain organization shown in Figure 1-
3C). In addition, Mdn1 and dynein are close relatives in the AAA superfamily 
based on the alignment of primary sequences (Kressler et al., 2012; Ulbrich et 
al., 2009). Therefore, Mdn1 has been regarded as a dynein-like AAA protein. 
However, the AAA domains in S. pombe Mdn1 share less than 15% identity 
with those in S. pombe dynein (see details in 1.4 Method). The rest of Mdn1’s 
sequence, which accounts for more than 50% of the total protein, does not 
share similarities with dynein. Therefore, it has been difficult to develop 
reliable models for Mdn1 function based on our understanding of dynein or 
other AAA proteins.  
1.3 Previous biochemical and structural characterization of Mdn1 
Alignment of primary sequences of Mdn1 orthologs reveals a conserved 
domain organization from yeasts to human proteins (Figure 1-4). As an 
example, S. pombe Mdn1 has a small domain at the N terminus, named the N 
domain (~130 aa in S. pombe Mdn1), followed by six AAA domains, and a 
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‘tail’, which is comprised of the linker, Asp/Glu-rich (D/E-rich), and MIDAS 
domains (Figure 1-3C). Currently, the biochemical studies of Mdn1 are limited, 
partially due to its large size (~5000 amino acids in a single polypeptide) and 
the difficulties in obtaining recombinant full-length protein for in vitro 
biochemical and structural studies.  
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Figure 1-4. Sequence alignment of Mdn1 orthologs. The sequences were 
aligned and displayed in Jalview (Waterhouse et al., 2009). Domain 
boundaries and selected structural and catalytic motifs are marked. The 
numbers following the Walker A, Walker B and arginine finger motifs indicate 
the AAA domain in which they are located (e.g. Walker A2 denotes the Walker 
A motif in the AAA2 domain). Secondary-structure elements in S. pombe Mdn1 
were predicted using SPIDER2 (Yang et al., 2017) and the potential α-helices 
(black cylinders) and β-strands (grey arrows) are shown above the S. pombe 
sequence. Residues that are important for the interaction between the MIDAS 
domain and Rsa4 in S. cerevisiae are indicated (magenta triangles for Asp- 






Mdn1 is required for the removal of assembly factors, including Ytm1 
and Rsa4 from Nsa1 and Rix1 particles, respectively (Bassler et al., 2010; 
Ulbrich et al., 2009). The N-terminal AAA domains in Mdn1 is likely capable of 
harnessing the energy from ATP hydrolysis and then provide the driving force 
for the remodeling of pre-60S particles. Consistent with this notion, mutants 
defective in ATP hydrolysis in Mdn1 was found to be non-functional in cells 
(Barrio-Garcia et al., 2016; Matsuo et al., 2014). On the other hand, the C-
terminal MIDAS domain interacts with assembly factors Rsa4 and Ytm1, and 
disruption of either interaction leads to retention of early factors on ribosome 
intermediates (Bassler et al., 2010; Ulbrich et al., 2009). The key question is 
how are conformational changes or force generated by the N-terminal AAA 
domains transmitted to the C-terminal MIDAS domain, thus to its associated 
assembly factors in the pre-60S particles. This question is challenging to 
address as the AAA and MIDAS domains are separated by ~2000 amino acids 
that share little readily detectable homology with other well-studied proteins, 
leaving their biochemical functions unknown in this unusually large protein. 
Previous negative-stain electron microscopy (EM) studies suggest a 
model for how Mdn1’s conformational changes during its ATPase cycle are 
coupled to its function (Ulbrich et al., 2009). Two-dimensional (2D) averages of 
S. cerevisiae Rea1 reveal that it has a hexagonal ring-shaped structure 
(diameter ~15 nm) that is similar to other AAA proteins like ClpX or dynein. In 
addition, an elongated ‘tail’ (~20 nm) extending from the ring structure at 
different relative orientations was also observed. It was assumed that the C-
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terminal MIDAS domain of Mdn1 lies at the tip of the elongated ‘tail’ so that the 
changes of relative orientations between the ring and tail will lead to 
movement of the MIDAS domain. In this model, the entire ~20-nm tail can 
transmit force, similar to the lever-arm motion described for dynein or myosin 
(Schmidt et al., 2015; Spudich, 2001), from the AAA domains to the MIDAS 
domain (Bassler et al., 2010). An alternative hypothesis was also proposed 
that long-range structural communication may exist between the AAA and 
MIDAS domains and conformational changes could propagate across the tail 
formed by ~2000 aa, similar to the conformational communication between the 
AAA ring and MTBD domain at the tip of the stalk in dyneins (Ulbrich et al., 
2009). However, the exact position of the MIDAS domain cannot be 
determined due to the limited resolution in these studies. High-resolution data 
are needed to determine if these proposed models explain Mdn1 function.  
The cryo-EM structure of the nucleoplasmic Rix1 particle at ~7 Å 
provides insights into how Mdn1 and its client protein Rsa4 bind the core of 
the pre-60S particle. In particular, the AAA ring of Mdn1 interacts with the core 
of the pre-60S particle through a limited portion of its outer edge (Figure 1-5). 
The C-terminal tail of Mdn1 could not be resolved in the map, leaving 
localization of MIDAS domain unknown. On the other hand, while Rsa4 
locates in close proximity to the AAA ring of Mdn1, robust density with 
unknown identities can be observed between the AAA ring and the N-terminal 
domain of Rsa4. How Mdn1 interacts with Rsa4 in the pre-60S particle and 
then drive its release remains to be an open question. 
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Figure 1-5. Cryo-EM density map of the Rix1 particle and models for 
Mdn1 and Rsa4. (A and B) Two views of the density map of the S. cerevisiae 
Rix1 particle with models for Mdn1 and Rsa4. In particular, the model for Mdn1 
is based on the published model (PDB: 5FL8) for the Rix1 particle map 
(EMDB: 3199) and the model for Rsa4 crystal structure (cyan, C. 
thermophilum, PDB: 4WJS) is placed into the same map based on the 
published model (PDB: 5FL8). In (A), unassigned density with unknown 
identity is indicated. The hexagonal AAA ring of Mdn1 is outlined in (B). For 
clarity, models for other components of the Rix1 particle are omitted. 
1.4 Outline 
Conventional genetic analyses, using temperature sensitive strains or 
overexpression of dominant-negative mutants, suppress protein function over 
hours. These approaches may not be suitable to study the dynamic steps of 
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ribosome biogenesis that are completed within minutes, especially when the 
protein is involved in multiple stages of the same process, such as Mdn1. In 
order to dissect the functions of protein like Mdn1 in living cells, we need acute 
inhibition so that we can distinguish between direct effects of Mdn1 inhibition 
from cumulative defects resulting from blocking earlier stages of ribosome 
biogenesis. However, we currently lack selective perturbation tools to trap 
transient intermediates of ribosome biogenesis, in particular for the steps 
require the dynamic function AAA proteins. In addition, how Mdn1 performs its 
key remodeling function remains poorly understood due to the lack of 
biochemical and structural characterization of this unusually large protein.  
In order to address these limitations, I sought out to (i) develop cell-
permeable chemical inhibitors for Mdn1; (ii) establish purification strategies 
and biochemical assays for the full-length recombinant Mdn1; (iii) perform 
cryo-EM analysis of recombinant Mdn1 at different nucleotide states. 
In the second chapter, I present the discovery of Ribozinoindoles 
(Rbins) as the first potent and selective chemical inhibitors of Mdn1 in S. 
pombe. I then focus on biochemical reconstitution and characterization of 
recombinant full-length S. pombe Mdn1. Using the purified protein and 
established biochemical assays, I then validate Mdn1 as the physiological 
target of Rbins in cells. 
The subsequent chapters focus on structural characterization of Mdn1 
in the presence of different nucleotides, nucleotide analogs and Rbin-1 using 
negative-stain EM (Chapter 3) and cryo-EM  (Chapters 4 and 5). In particular, I 
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present three cryo-EM structures of full-length or truncated S. pombe Mdn1, 
up to the resolution of 4.0 Å, at two different nucleotide states. These 
structures reveal unexpected intramolecular dynamics of Mdn1, which is very 
different compared to dyneins, and also suggest a mechanism of how Mdn1 
contribute to ribosome biogenesis. 
Based on my work, I present the final chapter as a summary and an 
outlook in which I discuss the potential future application of Rbins to dissect 
the functions of Mdn1 and other biophysical experiments to study the 
mechanochemical cycle of Mdn1. 
1.5 Methods 
Protein sequence alignment and comparison. The sequences of Mdn1 
orthologs (S. pombe Mdn1, Uniprot: O94248; S. cerevisiae Mdn1, Uniprot: 
Q12019; B. taurus Mdn1, Uniprot: E1BC24; H. sapiens Mdn1, Uniprot: 
Q9NU22) were aligned in ClustalW, which was also used to align and analyze 
the sequences of the AAA domains from S. pombe Mdn1 (Uniprot: O94248, 
aa 1-2196) and S. pombe dynein (Uniprot: O13290, aa 1852-4196). 
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CHAPTER 2 
INHIBITORS OF RIBOSOME BIOGENESIS THAT TARGET MDN1 
Note to readers: the results discussed below arose from a collaborative effort 
between myself and several colleagues in the Kapoor Lab at The Rockefeller 
University and the Kawashima lab at The University of Tokyo. A closely 
related version was published in Cell (DOI: 10.1016/j.cell.2016.08.070). With 
the permission of Prof. Kapoor, I have included relevant studies done by the 
others in the 2.2 Background section as they explain the rationale of my work. 
In 2.3 Results section, I focus mostly on work done by myself unless otherwise 
noted in the figure legend. In addition, I included Appendix 2 as a summary of 
collaboration between myself, several colleagues in the Kapoor lab and Tri-
Institutional Therapeutic Discovery Institute on the development of antifungal 
reagents based on our discovery. 
2.1 Introduction 
Cell-permeable chemical inhibitors can be powerful tools for examining 
dynamic cellular processes, such as ribosome biogenesis, as the functions of 
target proteins can be blocked within minutes. Currently, the only known 
chemical inhibitor that directly targets eukaryotic ribosome assembly factors is 
diazaborine, a compound that is active only at ~0.4 mM in S. cerevisiae (Loibl 
et al., 2014), a concentration at which selective target inhibition may be difficult 
to achieve. Moreover, since diazaborine blocks cytoplasmic steps (i.e. pre-60S 
maturation) of ribosome biogenesis, we lack chemical probes for the distinct 
assembly steps that occur in the nucleolus and nucleus. Lamotrigine is 
another chemical inhibitor of ribosome assembly factors that has been recently 
described (Stokes et al., 2014). However, this compound has been shown to 
only block ribosome biogenesis in E. coli at low temperatures (Stokes et al., 
2014).  
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In this study, we identify ribozinoindoles (or Rbins), as potent, reversible 
and specific inhibitors of Mdn1. Systematic genetic analyses of Rbins’ 
sensitivity and resistance in fission yeast, along with biochemical 
characterization of Mdn1’s ATPase activity, indicate that Rbins directly and 
specifically inhibit Mdn1 function in vitro and in cells. 
2.2 Background: Discovery of a chemical inhibitor of Mdn1, Rbin-1
To identify cell-permeable chemical probes of essential cellular 
processes we have developed fission yeast as a model system that allows us 
to efficiently combine genetic and chemical approaches (Aoi et al., 2014; 
Kawashima et al., 2012). In particular, we have generated fission yeast strains 
(named ‘MDR-sup’ strains) lacking critical factors for multi-drug resistance (or 
MDR) and have used them for chemical screens that mimic synthetic lethal 
genetic screens (Kawashima et al., 2012, 2013). We hypothesized that 
compounds that reveal enhanced toxicity to strains with a particular mutation, 
compared to a control strain, are likely to be more selective for a single protein 
target. Consistent with this hypothesis, our use of this strategy identified a 
selective inhibitor for Aurora kinase, a key cell cycle regulator (Kawashima et 
al., 2013). From a similar ‘chemical synthetic lethal’ screen carried out with a 
10,353-member library of diverse chemicals we identified a triazinoindole-
based heterocycle, which we named ribozinoindole-1 (or Rbin-1), that was 
more toxic to the MDR-sup cells that contained a mutation in cut2, compared 
to those with a wild-type cut2+ or a mutation in cut1 (Figures 2-1A and B). Both 
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Cut1 and Cut2 are essential proteins needed for faithful chromosome 
segregation (Funabiki et al., 1996). Subsequent analyses indicated that Rbin-
1’s ‘synthetic lethality’ was not due to a chromosome mis-segregation (‘cut’) 
phenotype (Figure 2-1C). In addition, we found that reverting the cut2 mutation 
to wild-type cut2+ did not suppress Rbin-1 sensitivity (Figure 2-1D). Together, 
these data indicate that the increased sensitivity to the chemical inhibitor was 
due to other ‘background’ mutations that were likely introduced when the 
mutant strain was first generated (Hirano et al., 1986).  
To examine the mode-of-action of Rbin-1 we back-crossed the cut2 
mutant MDR-sup strain with wild-type cut2+ MDR-sup and then analyzed the 
entire genome for mutations. Sequencing analysis identified 4 genes 
(SPCC737.08, SPAC14C4.01c, SPAC26A3.01, and SPAC26A3.05) bearing 
mutations, among which we found that a point mutation (Leu1113Phe) in the 
mdn1 (SPCC737.08) gene confers sensitivity to Rbin-1 in engineered fission 
yeast strain, suggesting that this residue is the background mutation that 
increases the sensitivity of fission yeast to Rbin-1. 
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Figure 2-1. Characterization of Rbin-1, a potent chemical inhibitor of cell 
growth. (A) MDR-sup (WT), MDR-sup cut1-22 (cut1ts), and MDR-sup cut2-
364 (cut2ts) cells were incubated with different concentrations of Rbin-1 (17 h, 
29°C). Growth (%) is presented relative to DMSO-treated cells (mean±SD, 
n=3 independent experiments). (B) Chemical structure of Rbin-1. (C) Nuclear 
morphology of MDR-sup cells, MDR-sup cut1-22 (cut1ts) and MDR-sup cut2-
364 (cut2ts) cells at 36°C (restrictive temperature), and MDR-sup cells treated 
with 10 μM Rbin-1 (+Rbin-1) were examined. Representative images are 
shown. Cells with ‘cut’ phenotype, observed in temperature-sensitive cut1 or 
cut2 mutants, are highlighted (yellow arrowheads). Scale bars, 10 μm. (D) 
cut2-364 (cut2ts) and a cut2ts-rev strain (with the cut2-364 mutation reverted to 
wild-type cut2+) were incubated (17 h) with indicated concentrations of Rbin-1 
at 29°C or untreated at 37°C. Growth (%) is presented relative to DMSO-
treated cells incubated at 29°C (mean±range, n=2 independent experiments). 
(E) Domain organization of the S. pombe Mdn1 protein (SpMdn1). The AAA 
domains, linker, Asp/Glu-rich region and MIDAS domain are highlighted. 
Locations of a Rbin-1-sensitivity-conferring mutation (red), Rbin-1-resistance-
conferring mutations obtained by error-prone PCR of mdn1 gene (green), and 
Rbin-1-resistance-conferring mutations obtained using a chemical mutagen 
(blue) are indicated. (F) Serial dilutions of the indicated mdn1 mutants were 
spotted onto YE4S plate, or YE4S plate containing indicated compounds, and 
incubated at 29°C for two days. (G) Wild-type and indicated mdn1 mutants 
were incubated for 17 h at 29°C with indicated concentrations of Rbin-1. 
Growth (%) is presented relative to DMSO-treated cells. 
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To further address the mode of action of Rbin-1, we chemically 
mutagenized the MDR-sup fission yeast cells and isolated resistant clones that 
can grow in the presence of Rbin-1. Each of the 13 Rbin-1 resistant clones 
contained one of five different point mutations in the mdn1 gene (Figures 2-1E 
and F). In separate experiments using a PCR-based random mutagenesis 
strategy, we isolated two additional mdn1 mutations that confer Rbin-1-
resistance (Figures 2-1E and F). We next confirmed, using overexpression on 
plasmids in MDR-sup cells and by replacement of endogenous mdn1 in wild-
type cells, that all the mutations we identified were sufficient to confer 
resistance to Rbin-1 (Figures 2-1F and G). Importantly, these mutations did 
not confer resistance to cycloheximide, another chemically unrelated inhibitor 
(Figure 2-1F). Interestingly, all seven of these resistance-conferring mutations 
and the sensitivity-conferring mutation clustered around two (AAA3 and AAA4) 
of the six AAA domains in Mdn1 (Figure 2-1E). These data are consistent with 
a hypothesis that Rbin-1 target Mdn1 or another protein along the same 
pathway of Mdn1 function in cells so that mutations in mdn1 can affect the 
compound activities. 
As Mdn1 has been linked to remodeling of precursors of 60S ribosome 
subunits in budding yeast before, we next examined if Rbin-1 indeed perturb 
ribosome biogenesis in fission yeast cells. We found that nuclear export of the 
pre-60S subunit, which can be tracked using Rpl2501-GFP, a homolog of 
budding yeast Rpl25 (Hurt et al., 1999), was blocked in Rbin-1-treated cells 
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(Figures 2-2A and B). Importantly, this defect was not observed in Rbin-1-
treated mdn1-F1093L mutant cells (Figure 2-2A). In addition, this defect was 
also observed at the restrictive temperature in a mdn1 temperature-sensitive 
mutant strain (Figure 2-2C). In contrast, the nuclear export of the pre-40S 
subunits that were tracked using two different reporters, Rps2-GFP and Rps3-
GFP (Galani et al., 2004), was not blocked in Rbin-1-treated cells (Figure 2-
2D), suggesting that Rbin-1 perturb specific steps of ribosome biogenesis that 
leads to block of the nuclear export of pre-60S particles but not pre-40S 
particles. Further, by comparing Rpl2501-GFP with Gar1-mCherry (nucleolus 
marker) and DAPI (DNA marker), we found that pre-60S particles accumulated 
in the nucleolus upon Mdn1 inhibition (Figures 2-2B and C). This inhibition can 
be observed within 30 mins after addition of Rbin-1 and reached a maximum 
level in 90-120 min (Figures 2-2E and F). Relief from Rbin-1 treatment 
revealed stepwise reductions in the nucleolar signal, with Rpl2501-GFP levels 
reducing substantially (~47%) within 5 min of washout, then another ~37% 
between 20-30 min, and ~15% between 40-60 min (Figure 2-2F), suggesting 
three distinct ribosome intermediates were trapped upon the addition of Rbin-
1.  
The data showing that Rbin-1 treatment phenocopies the loss of 
function of Mdn1 in the temperature-sensitive mutation strain are consistent 
with a hypothesis that Rbin-1 directly inhibit the activity of Mdn1 thus 
suppresses its ribosome biogenesis function and the cellular growth. 
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Considering that Mdn1 is an AAA ATPase, it is possible that Rbin-1 can inhibit 
the ATPase activity of Mdn1. 
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Figure 2-2 Rbin-1 causes blockage of nuclear export of pre-60S particles 
and phenocopies the temperature-sensitive-mdn1 strain at non-
permissive temperate in fission yeast. (A) Rpl2501-GFP signals in wild-type 
(WT) and mdn1-F1093L cells with or without Rbin-1 treatment (1 μM) were 
examined. Scale bars, 10 μm. (B) Rpl2501-GFP signals (green) were 
compared with nucleolar marker Gar1-mCherry (red) and DNA (blue). Scale 
bars, 2 μm. (C) Rpl2501-GFP signals in mdn1-ts26 cells at 25°C or 36°C for 6 
hours were examined. Also shown are images of Rpl2501-GFP, Gar1-
mCherry (red), and DNA stained with DAPI (blue). Scale bars, 2 μm. (D) The 
localization of markers for the 40S pre-ribosome, Rps2-GFP and Rps3-GFP 
(green, overlaid on the corresponding DIC image, red), was examined in the 
presence or absence of Rbin-1 (1 μM). Scale bars, 2 μm. (E, Rpl2501-GFP 
localization was examined in asynchronous cells (0 min), 1 μM Rbin-1-treated 
cells (30-120 min), and in cells after washing out Rbin-1 (wo-5-60 min) at 
29°C. Representative images are shown in (E). Scale bars, 10 μm. The signal 
intensity of Rpl2501-GFP in the nucleolus was measured in (F). Averages are 
indicated by black bars (n=80 cells). Asterisks indicate unpaired two-tailed 




2.3.1 Structure-activity-relationship analysis of Rbin-1 
We next optimized the chemical inhibitor’s potency by generating a 
focused collection of analogs. Seventeen compounds were synthesized by 
condensing isatin (or derivatives) with hydrazinecarbothioamide, and further 
elaborated using halogenated aliphatic and aromatic moieties (Figure 2-3). 
This procedure yielded Rbin-1 analogs in >95% purity and 7-65% overall yield 
(see 2.5 Method section). Dose-dependent analyses were used to determine 
the potency of these analogs in growth assays (Figure 2-3B). Our studies 
reveal that alkyl substituents at the 3-thiol position result in compounds with 
activities that are reduced compared to that of Rbin-1 (Analogs 2-5 in Figure 2-
3B). A benzyl moiety at the 3-thiol position increased potency but reduced 
solubility (Rbin-3 or Analog 6 in Figure 2-2B) while a pyridine moiety abolishes 
the activity (Analog 7). Larger aromatic substitutions at this position reduced 
compound activity (Rbin-5 or Analogs 8 in Figure 2-3B). Modification of the 
benzyl moiety by nitro, methoxy or iodine leads to inactive compounds 
(Analogs 9-11), while the ortho-fluoride benzyl Rbin has very similar activity as 
Rbin-3 (Analogs 6 and 12). A homo-propargyl modification at the indole 
nitrogen (R2 position) also resulted in an inactive analog (Rbin-6 or Analog 21 
in Figure 2-3B). We found that the most striking changes in activity resulted 
from modifications of the A-ring (Figure 2-3A). In particular, an analog (Rbin-2 
or Analog 15 in Figure 2-3B) with a bromine substituent at position-7 was ~10- 
fold more active than Rbin-1 (GI50=14 ± 1 nM (Rbin-2); 136 ± 7 nM (Rbin-1), 
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n=4, mean±SD). In contrast, an iodine substituent at position-8 suppressed 
activity (Rbin-7 or Analogs 22 and 23 in Figure 2-3B). Combinations of the 
bromine substituent at position-7 and benzyl or alkyl substituents on the thiol 
atom did not yield more active compounds (Analogs 16-17). 
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Figure 2-3. Structure-activity-relationship analysis of Rbin-1 analogs. (A) 
Synthesis scheme for RBin analogs. (B) Structure-activity relationship of Rbin 
analogs. Compounds were added to wild-type cells in diluted culture (in 
logarithmic phase, OD600 ~ 0.01) and the mixture was incubated for ~18 h at 
29°C till OD600~1 for DMSO control. Half maximum growth inhibition (GI50, 
mean±SD, n=3 independent experiments) was determined by fitting relative 
growth to a four-parameter sigmoidal dose-response curve in PRISM. For 
compounds that inhibited growth by less than 50% at 500 nM and 2500 nM, 
we indicate GI50 to be ”≥ 500 nM” and ”≥ 2500 nM” respectively.  For a few 
compounds, dose-dependent inhibition could not be readily fit to standard 
equations, likely due to limited compound solubility (Note: *: The number of 
analogs were assigned in the published manuscript and analogs I synthesized, 
except Analog 21, are shown; **: Analogs 21, synthesized by Dr. Anupam 
Patgari, is shown since it was used later in the biochemical assay as a 
negative control; ***: The analysis of the activities were carried out by myself 
and Dr. Patgari together). 
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I next confirmed that Rbin-2 activity against the strain expressing the 
resistance-conferring mutation (mdn1-F1093L) was substantially reduced, 
while activity against the strain expressing the sensitivity-conferring mutation 
(mdn1-L1113F) was increased relative to the wild-type strain (Figure 2-4). 
Together, these tests identify Rbin-2 as a potent Rbin-1 analog that is likely to 
have a similar mechanism of action. 
Figure 2-4. Growth inhibition of wild-type or mutant S. pombe strains by 
Rbin-2. The growth of wild-type and mutant S. pombe strains in the presence 
of different concentrations of Rbin-2 were analyzed by the OD values. The 
normalized growth relative to the DMSO control is plotted. Rbin-2 is more toxic 
to the Rbin-1-sensitive strain (with L1113F mutation in mdn1) and significantly 
less toxic in Rbin-1-resistant strains (with E1187K or D1123E mutation in 
mdn1). 
2.3.2 Biochemical characterization of Mdn1 in vitro 
To date, only S. cerevisiae Rea1 has been expressed and purified as a 
recombinant form. However, its ATPase activity has not been measured. S. 
pombe Mdn1 has not been purified nor characterized. To analyze S. pombe 
Mdn1’s ATPase activity and examine inhibition by Rbin-1 we need to purify 
recombinant Mdn1 for in vitro biochemical assays. I employed the insect cell 
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system to generate recombinant Mdn1. After significant optimization, I 
developed a multi-step strategy, which included nickel affinity, ion-exchange 
and size-exclusion chromatography (Figure 2-5A). In the final purification step, 
Mdn1 eluted from a size-exclusion column at a volume (10.6 ml, Void: 7.5 ml) 
consistent with its large size (M.W. ~542 kDa for hexahistidine-tagged Mdn1) 
and elongated shape based on analyses of Rea1 (Figures 2-5B and C) 
(Nissan et al., 2004; Ulbrich et al., 2009). A typical purification yielded ~0.1 mg 
of recombinant Mdn1 per 3L cell culture. Mass spectrometry confirmed that 
the single band resolved by SDS-PAGE was Mdn1, as we were able to identify 
339 unique peptides that covered >70% of the Mdn1 sequence (Figure 2-5D). 
In particular, the identified peptides confirmed the presence of ~80 amino 
acids at Mdn1’s C-terminus. These data, along with the N-terminal tag-based 
isolation, indicate that we are able to purify full-length recombinant Mdn1.   
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Figure 2-5. Rbins inhibit Mdn1’s ATPase activity in vitro. (A) Schematic for 
strategy used to purify recombinant full-length Mdn1. (B) The size-exclusion 
chromatography profile for Mdn1 (black trace). The activity of different 
fractions from this chromatography step was analyzed using a radioactive 
ATPase assay ([MgATP]= 0.1 mM). Activity was normalized to the most active 
fraction (red dots: each fraction, trace: interpolation). (C) SDS-PAGE analysis 
of purified full-length Mdn1 (WT) (Coomassie stain). (D) Peptides identified by 
mass spectrometry of the purified protein are indicated (green bars, schematic 
generated using Proteome Discoverer 1.4, Thermo Scientific). (E) Mdn1’s 
activity in the presence of Rbin analogs (1 μM) was tested using an NADH-
coupled ATPase assay ([MgATP]= 1 mM). The average relative activity and 
range (bars) are indicated (n=2 independent experiments). (F) Dose-
dependent inhibition of the steady-state ATPase activity of wild-type Mdn1 and 
resistant F1093L Mdn1 by Rbin-2 (mean±SD, n=4 independent experiments). 
An apparent EC50 was estimated for the inhibition of wild-type Mdn1 using a 
sigmoidal dose-response curve. Using similar equations we were unable to 
properly fit the small decrease in activity of F1093L-Mdn1 across the 
concentration range tested. Unpaired T-tests (without Welch’s correction) of 
the measured activity for WT and F1093L-Mdn1, at the highest three inhibitor 
concentrations tested, indicate that the differences in values are statistically 
significant (p= 0.0020 (at 16.7 μM), p= 0.0021 (at 3.33 μM) and p= 0.0019 (at 
1.0 μM)). (G) The ATPase activity of Mdn1 in the presence Rbin-1 (1 μM) or 
AMP-PNP (2 mM) using a radioactive ATPase assay ([MgATP] = 0.1 mM). (H) 
SDS-PAGE analysis of purified full-length F1093L-Mdn1 (Coomassie stain).
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I then analyzed the ATPase activities of different fractions eluted from 
size-exclusion chromatography utilizing a radioactive-ATP based assay. The 
levels of ATPase activities closely matched the UV profile of the elution peak 
of Mdn1 (Figure 2-5B, red trace). We next examined the steady-state ATPase 
activity of Mdn1 using an NADH-coupled enzyme assay. The specific activity 
of Mdn1 was ~1.0 s-1 at 1 mM ATP. These data indicate that Mdn1 is an 
ATPase with specific activity comparable to that of other AAA+ proteins, such 
as VPS4 and dynein (Kon et al., 2004; Yang et al., 2015). 
We next examined the inhibition of Mdn1’s steady-state ATPase activity 
by Rbin-1 and analogs. Two of the active analogs (Rbin-1 and Rbin-2) 
inhibited the ATPase activity by ~40% at 1 μM (Figure 2-5E). Under similar 
conditions, analogs, i.e. Rbin-5, 6 and 7, that were inactive in cell-based 
assays did not suppress ATPase activity (Figure 2-5E). As the amounts of 
Mdn1 were limiting, we focused on the dose-dependent inhibition of Mdn1 
activity by Rbin-2, the most potent analog. While increasing concentrations of 
Rbin-2 resulted in greater inhibition, the dose-dependent inhibition saturated at 
~50%, consistent with inhibition of a subset of the ATPase domains in Mdn1. 
For the observed dose-response curve, we can estimate an apparent EC50 
(~0.3 μM, Figure 2-5F). For comparison, we find that almost complete 
inhibition of the ATP hydrolysis (in a radioactive assay) can be achieved by a 
non-hydrolyzable ATP analog (AMPPNP, 2 mM), while Rbin-1 (1 μM) only 
inhibited activity by ~40% (Figure 2-5G) in the radioactive-ATP assay. It is 
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likely that Rbin analogs only suppresses a subset of the ATPase sites in 
Mdn1, while the cellular function of Mdn1 requires activities of all ATPase sites 
so the partial inhibition in vitro leads to full inhibition of the growth of yeast. 
To establish that Mdn1 is Rbins’ direct target we generated full-length 
recombinant Mdn1 containing a mutation (F1093L) that confers resistance to 
the Rbins in cell-based assays (hereafter, F1093L-Mdn1, Figure 2-5H). We 
find that F1093L-Mdn1 is an active enzyme whose ATPase activity (1.5 ± 0.2 
ATP s-1) in the steady-state assay is comparable to that of wild-type Mdn1. 
Importantly, Rbin-2 does not strongly suppress the ATPase activity of the 
F1093L-Mdn1 (Figure 2-5F). Together, these data establish what we refer to 
as ‘gold standard’ proof that the physiological target of Rbins is Mdn1, as the 
same single-point mutation can suppress inhibition by Rbins in both cell-based 
and in vitro biochemical activity assays (Wacker et al., 2012). 
2.4 Discussion 
Here, we report the discovery of ribozinoindoles, potent and selective 
chemical inhibitors for Midasin, an essential AAA+ protein required for 
eukaryotic ribosome biogenesis. Matched inhibitor-sensitive and inhibitor-
resistant cells allow systematic analyses of dose-dependent target-specific 
effects of the chemical probe, addressing a major potential limitation of the use 
of chemical inhibitors to examine cellular mechanisms. Further, the fast 
timescale of Mdn1 inactivation and activation by Rbins is well suited to dissect 
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its role in coordinating the spatial and temporal dynamics of ribosome 
biogenesis. 
Importantly, the timescale of Midasin inactivation and activation by 
Rbin-1 (less than 30 min) is significantly faster than what we can achieve 
using genetic approaches (~3-6 h using our temperature-sensitive allele). In 
particular, the temporal control over target function that can be achieved with 
these chemical probes is evident from studies of Rpl2501 localization, which 
are altered in live cells within 30 min of inhibitor washout (Figure 2-2E). 
Analyses of the timescales over which different phenotypes accumulate 
following chemical inhibitor treatments can guide interpretations and help 
develop models for target protein function in a dynamic, ordered, multi-step 
cellular process, such as eukaryotic ribosome biogenesis. It is likely that 
Rbins, which allow acute and reversible inhibition of Mdn1, will help dissect 
these fast assembly dynamics.  
Mdn1 and the closely related motor protein dynein are the only known 
members of the AAA+ protein family that have all six AAA domains on a single 
polypeptide, a feature that likely allows functional specialization of each of the 
multiple AAA domains (Carter, 2013). In the case of dynein, which has been 
extensively studied over the last couple of decades, two of its ATPase sites 
contribute to the overall ATP hydrolysis and directional transport activity 
(Carter, 2013). As Rbin-resistance and -sensitivity conferring mutations cluster 
at one ATP binding site in Mdn1, we favor the possibility that Rbins act 
through inhibiting the activity of the ATPase site formed by AAA3 and AAA4 
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domains. Additional structural and biochemical studies will be needed to test 
this hypothesis.   
Our discovery of a specific and potent chemical inhibitor of Midasin, 
along with the findings that dynein and p97/VCP can be selectively inhibited 
by cell-permeable low molecular weight compounds (Anderson et al., 2015; 
Chou et al., 2011; Firestone et al., 2012), indicate that drug-like inhibitors can 
be developed for AAA+ proteins. These discoveries lay the foundation for 
developing pharmacophore models for rationally designing chemical inhibitors 
for AAA+ proteins for which we lack chemical probes, such as proteins 
involved in DNA replication, mitochondrial function or cytoskeleton 
organization. 
2.5 Methods 
Methods related to the generation of S. pombe strains can be found in 
Kawashima et al. 2016.  
SAR analysis of Rbin analogs using a growth assay of pombe. 
S. pombe strains were grown to exponential phase and diluted to OD600 
~ 0.001. 1 μL DMSO or DMSO solution of Rbins (1000x) were mixed with 1 
mL diluted culture. The cells were placed in a shaker (220 rpm) for 18 hours at 
29 °C till OD600 of DMSO control reached ~1. Relative growth was calculated 
by dividing the measured OD at a specific concentration by the OD for the 
DMSO control. Half maximum growth inhibition (GI50) was determined by 
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fitting relative growth to a four-parameter sigmoidal dose-response curve in 
PRISM. 
Purification of recombinant S. pombe Mdn1 
The cDNA encoding fission yeast Mdn1 was cloned into pFastBac HTC 
vector (Invitrogen). We used the Bac-to-Bac system (Invitrogen) to generate 
recombinant baculovirus. High Five cells (Life Technologies) were grown in Sf-
900 II SFM (Life Technologies 10902-096) with 1X Antibiotic-Antimycotic (Life 
Technologies) to ~2.5 million/mL and then infected (1:80 dilution of P2 virus). 
The cells were harvested 60 h after infection. All of the following steps were 
done on ice or at 4 °C. The cells were lysed by sonication in an equal volume 
of lysis buffer (50 mM Tris [pH 7.5], 400 mM NaCl, 20 mM imidazole, 1 mM 
MgCl2, 5 μM 2-mercaptoethanol, 200 μM ATP, 3 U/mL benzonase, 1X Roche 
complete protease inhibitor without EDTA, 10% glycerol). The homogenized 
lysate was then centrifuged at 55,000 rpm for 1 h. The supernatant was 
incubated with Ni-NTA beads (Qiagen) for 40 min. The beads were extensively 
washed using Washing buffer (50 mM Tris [pH 7.5], 400 mM NaCl, 20 mM 
imidazole, 1 mM MgCl2, 5 μM 2-mercaptoethanol, 200 μM ATP, 10% glycerol). 
The protein was then eluted by high-imidazole buffer (20 mM Tris [pH 7.5], 
120 mM NaCl, 300 mM imidazole, 1 mM MgCl2, 5 μM 2-mercaptoethanol, 200 
μM ATP). The eluted fraction was filtered and loaded onto a Mono Q column 
5/50 GL (GE Healthcare Life Sciences). The protein was eluted around 400 
mM NaCl and the fractions were collected and analyzed by SDS-PAGE. The 
relevant fractions were pooled and then concentrated using Amicon Ultra-4 
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Centrifugal Filter Units. The concentrated sample was then loaded onto a 
Superose 6, 10/300 GL column (GE Healthcare Life Sciences) using FPLC 
SEC buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM MgCl2, 1mM EGTA and 
1 μM DTT. Peak fractions were collected and ATPase assay was carried out 
directly with fresh protein. A typical yield of these preparations is ~ 0.1 mg/ 3 L 
culture. Freshly purified Mdn1 was used immediately for EM studies. 
Radioactive ATPase Assay 
Radioactive γ-P32-ATP (PerkinElmer, BLU002Z250UC) was added to 
600 μM MgATP (pH 7.0) solutions at volume ratios of 1:1000-1:300, 
depending on the lifetime of the radioactive reagent. The total volume of each 
reaction was 12 μL, including 6 μL of protein from size exclusion 
chromatography fractions (final concentration ~ 0-50 nM for different fractions, 
peak fractions were used for Rbin-1 and AMPPNP inhibition experiment in 
Figure 2-5), 4 μL FPLC SEC buffer with 3 mM Na2SO4 and 2 μL MgATP (final 
concentration = 100 μM). The reactions were then incubated at room 
temperature for 30~60 min before quenching with 12 μL 0.2 M EDTA. 1 μL 
from each reaction mixture was spotted on TLC PEI cellulose F plates 
(Millipore, 105579). The TLC buffer contained 0.15 M formic acid and 0.15 M 
lithium chloride. The TLC plates were then imaged by the Typhoon Scanner 
9400 (GE Healthcare Life Sciences). ImageJ was used to calculate the 
densitometric ratio of the spots corresponding to radioactive free phosphate 
and ATP to calculate the percent of ATP hydrolyzed. 
NADH-coupled steady-state ATPase assay 
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For each steady-state ATPase reaction, the final volume was 30 μL. 
The final concentration of protein was 50 nM. The FPLC SEC buffer was used 
to dilute the sample. NADH (N7410), phosphoenol pyruvic acid 
monopotassium salt (P7127), D-lactic dehydrogenase (L3888) and pyruvate 
kinase (ammonium sulfate suspension, P1506) were added to final 
concentration of 140 μM, 1.25 mM, 40 U/mL and 80 U/mL. 1 μL 
DMSO/compound solution was added and mixed. 3 μL 10 mM MgATP (pH = 
7.0), was added to make the final total volume of 30 μL and final concentration 
of MgATP at 1 mM. Time course of fluorescence decrease due to NADH 
oxidation was measured using Synergy NEO Microplate Reader. The 
fluorescence values were plotted against time and fit by linear regression. The 
slopes of these lines were used to calculate the ATPase rate. The relative 
activities were obtained by dividing the measured activity by activity in DMSO 
control (no compound). The EC50 value for the inhibition of wild-type Mdn1 
was determined by fitting the average values for relative activity at each 
inhibitor concentration (n=4 independent measurements) to a four-parameter 
sigmoidal dose-response curve using PRISM. 
Chemical Synthesis 
Materials and instrumentation.  
Materials were purchased from Sigma-Aldrich and used without 
purification unless otherwise noted. Reactions were run in capped round 
bottom flasks stirred with Teflon®-coated magnetic stir bars. Moisture- and air-
sensitive reactions were performed in flame-dried round bottom flasks, fitted 
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with rubber septa or glass gas adapters, under a positive pressure of nitrogen. 
Moisture- and air-sensitive liquids or solutions were transferred via nitrogen-
flushed syringes. As necessary, solutions were deoxygenated by bubbling with 
nitrogen using a gas dispersion tube. Evaporation of solvents was 
accomplished by rotary evaporation using a Büchi rotary evaporator, equipped 
with a dry ice-acetone condenser, at 5-75 mm Hg at temperatures between 
35°C and 50°C. Experiments were monitored by thin layer chromatography 
(TLC) or liquid chromatography-mass spectrometry (LC-MS). The 
maintenance of 30 °C to 150 °C reaction temperatures was accomplished by 
the use of an oil bath. Products obtained as solids or high boiling oils were 
dried under vacuum (~1 mm Hg).  
Compounds were purified using silica gel column chromatography, as 
necessary. Analytical TLC was performed using Whatman 250 micron 
aluminum backed UV F254 precoated silica gel flexible plates. Subsequent to 
elution, ultraviolet illumination at 254 nm allowed for visualization of UV active 
materials. Staining with basic potassium permanganate solution allowed for 
further visualization.  
Proton nuclear magnetic resonance spectra (1H NMR) were recorded 
on Bruker DPX 400 MHz nuclear magnetic resonance spectrometer. Chemical 
shifts for 1H NMR spectra are reported as δ in units of parts per million (ppm) 
relative to tetramethylsilane (δ 0.0) using the residual solvent signal as an 
internal standard or tetramethylsilane itself: dimethylsulfoxide-d6 (δ 2.50, 
quintet) and deuterium oxide-d2 (δ 4.80, singlet). Multiplicities are given as s 
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(singlet), d (doublet), t (triplet), or m (multiplet). Coupling constants are 
reported as a J value in Hertz (Hz). The number of protons (n) for a given 
resonance is indicated by nH. 
Liquid chromatography-mass spectral analyses were obtained using a 
Waters MicroMassZQ mass spectrometer, with an electron spray ionization 
(ESI) probe, connected to a Waters 2795 HT Separation Module Alliance HT 
HPLC system running MassLynx (V4.0). The system used a Waters 996 
Photodiode Array Detector set to 254 nm for peak detection, and a 
Symmetry® C18 (3.5 micron) 2.1 x 50 mm column for separation (mobile 
phase for positive mode: solvent A: water with 0.1% formic acid, solvent B: 
acetonitrile; mobile phase for negative mode: solvent A: water with 0.1% 
morpholine, solvent B: acetonitrile). Values are reported in units of mass to 
charge (m/z) 
Synthesis of Rbin-1 analogs. 
Figure 2-6. Synthetic scheme of Rbin-1 analogs. 
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The synthesis method has been adapted from previous studies 
(Ivachtchenko et al., 2002). Briefly, a solution of thiosemicarbazide 2 (3.38 
mmol, 1 equivalent) in boiling water was added with stirring to a solution of 
isatin or substituted isatin 1 (3.38 mmol, 1 equivalent) in boiling ethanol. The 
resulting mixture was refluxed for 2h to form a precipitate of 
thiosemicarbazone 3, which was isolated by filtration and washed with ethanol. 
Thiosemicarbazone 3, was then transferred to a solution of sodium hydroxide 
(3.38 mmol, 1equivalent) in water and refluxed overnight. The reaction mixture 
was then cooled to room temperature and the pH of the solution was adjusted 
to 3 with dilute aqueous HCl (1:3, v/v) to get precipitates of 5. Triazinoindole 5 
was then recrystallized from ethanol or washed with hot ethanol to get pure 5 
and then dried in air. Thiosubstitution of 5 was achieved by the addition of the 
alkyl bromide 6 (0.335 mmol, 0.67 equivalents) to a stirring solution of 5 (0.5 
mmol, 1 equivalent) in 0.1 N NaOH (aqueous) and then refluxing the resulting 
mixture for 2h. The precipitated product was filtered, washed several times 
with water followed by hot ethanol to get pure 7. 
Characterizations of the Rbin analogs 
All chemical structures and naming of analogs are listed in Figure 2-3B. 
Note: I only included characterizations of sixteen compounds synthesized by 
myself. 
Analog 1 or Rbin-1 (ZC-3): 1H NMR (400 MHz, DMSO-d6) δ 1.84 (s, 3H), 
3.98 (s, 2H), 4.91 (s, 1H), 5.1 (s, 1H), 7.42 (t, J= 7.38 Hz, 1H), 7.56 (d, J= 8.0 
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Hz, 1H), 7.68 (t, J= 7.54 Hz, 1H), 8.29 (d, J= 7.64 Hz, 1H). ESI-MS (m/z) 
[M+H]+ Calculated: 257.33, found: 257.57. 
Analog 2 (ZC-9): 1H NMR (400 MHz, DMSO-d6) δ 3.96 (d, J= 6.68 Hz, 2H), 
5.16 (d, J= 9.84 Hz, 1H), 5.39 (d, J= 16.8 Hz, 1H), 6.04 (m, 1H), 7.43 (t, J= 
7.46 Hz, 1H), 7.52 (d, J= 8.0 Hz, 1H), 7.68 (t, J= 7.58 Hz, 1H), 8.30 (d, J= 8.0 
Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 243.30, found: 243.55. 
Analog 3 (ZC11): 1H NMR (400 MHz, DMSO-d6) δ 1.03 (t, J= 7.28 Hz, 3H), 
1.77 (m, 2H), 3.24 (t, J= 7.16 Hz, 2H), 7.43 (t, J= 7.44 Hz, 1H), 7.56 (d, J= 
8.04 Hz, 1H), 7.68 (t, J= 7.6 Hz, 1H), 8.29 (d, J= 7.68 Hz, 1H). ESI-MS (m/z) 
[M+H]+ Calculated: 245.32, found: 245.57. 
Analog 5 (ZC-51): 1H NMR (400 MHz, DMSO-d6) δ 0.37 (m, J= 4.81 Hz, 2H), 
0.58 (m, J= 5.9 Hz, 2H), 1.24 (m, 1H), 3.23 (d, J= 7.12 Hz, 2H), 7.43 (t, J= 
7.43 Hz, 1H), 7.56 (d, J= 8.08 Hz, 1H), 7.68 (t, J= 7.48 Hz, 1H), 8.30 (d, J= 7.7 
Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 257.33, found: 257.59. 
Analog 6 or Rbin-3 (ZC-28): 1H NMR (400 MHz, DMSO-d6) δ 4.56 (s, 2H), 
7.25 (t, J= 7.16 Hz, 1H), 7.32 (t, J= 7.22 Hz, 2H), 7.42 (t, J= 7.42 Hz, 1H), 
7.47-7.53 (m, 2H), 7.58 (d, J= 8.04 Hz, 1H), 7.70 (t, J= 7.6 Hz, 1H), 8.30 (d, J= 
7.64 Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 293.36, found: 293.62. 
Analog 7 (ZC-6): 1H NMR (400 MHz, DMSO-d6) δ 4.56 (s, 2H), 7.43 (t, J= 7.6 
Hz, 1H), 7.52 (d, J= 4.96 Hz, 2H), 7.56 (d, J= 8.08 Hz, 1H), 7.68 (t, J= 7.62 
Hz, 1H), 8.29 (d, J= 7.72 Hz, 1H), 8.50 (d, J= 3.72 Hz, 2H). ESI-MS (m/z) 
M+H]+ Calculated: 294.35, found: 294.59.  
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Analog 8 or Rbin-5 (ZC-10): 1H NMR (400 MHz, DMSO-d6) δ 4.74 (s, 2H), 
7.43 (t, J= 7.54 Hz, 1H), 7.49 (t, J= 3.69 Hz, 2H), 7.58 (d, J= 8.08 Hz, 1H), 7.6 
(m, 2H), 7.88 (d, J= 8.08 Hz, 3H), 8.04 (s, 1H), 8.30 (d, J= 7.6 Hz, 1H). ESI-
MS (m/z) M+H]+ Calculated: 243.42, found: 243.65. 
Analog 9 (ZC-5): 1H NMR (400 MHz, DMSO-d6) δ 3.73 (s, 3H), 4.53 (s, 2H), 
6.83 (d, J= 7.2 Hz, 1H), 7.08 (d, J= 7.12 Hz, 2H), 7.24 (t, J= 7.9 Hz, 1H), 7.43 
(t, J= 7.48 Hz, 1H), 7.58 (d, J= 8.04 Hz, 1H), 7.69 (t, J= 7.7 Hz, 1H), 8.31 (d, 
J= 7.6 Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 323.39, found: 323.67. 
Analog 10 (ZC-41): 1H NMR (400 MHz, DMSO-d6) δ 4.86 (s, 2H), 7.43 (t, J= 
7.52 Hz, 1H), 7.56 (m, 2H), 7.7 (t, J = 7.72, 2H), 7.90 (d, J= 7.72 Hz, 1H), 8.05 
(d, J= 8.12 Hz, 1H), 8.30 (d, J= 7.68 Hz, 1H). ESI-MS (m/z) [M+H]+ 
Calculated: 338.36, found: 338.61. 
Analog 11 (ZC-7): 1H NMR (400 MHz, DMSO-d6) δ 4.69 (s, 2H), 7.44 (t, J= 
7.6 Hz, 1H), 7.5 (d, J= 8.0 Hz, 1H), 7.69 (t, J= 7.6 Hz, 1H), 7.80 (d, J= 8.16 
Hz, 2H), 8.17 (d, J= 8.16 Hz, 2H), 8.30 (d, J= 7.68 Hz, 1H). ESI-MS (m/z) 
M+H]+ Calculated: 338.36, found: 338.60. 
Analog 12 or Rbin-4 (ZC-30): 1H NMR (400 MHz, DMSO-d6) δ 4.59 (s, 2H), 
7.16 (t, J= 7.44 Hz, 1H), 7.22 (t, J= 9.28 Hz, 1H), 7.33 (m, 1H), 7.43 (t, J= 7.48 
Hz, 1H), 7.58 (d, J= 8.08 Hz, 1H), 7.64 (t, J= 7.62 Hz, 1H), 7.69 (t, J= 7.64 Hz, 
1H), 8.31 (d, J= 7.72 Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 311.35, 
found: 311.57.  
Analog 15 or Rbin-2 (ZC-32): 1H NMR (400 MHz, DMSO-d6) δ 1.84 (s, 3H), 
3.98 (s, 2H), 4.91 (s, 1H), 5.12 (s, 1H), 7.58 (d, J= 8.28 Hz, 1H), 7.74 (s, 1H), 
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8.24 (d, J= 8.4 Hz, 1H). ESI-MS (m/z) [M]+ Calculated: 335.22, found: 335.45 
and [M+2H]+ Calculated: 337.22, found: 337.48 (bromine pattern). 
Analog 16 (ZC-33): 1H NMR (400 MHz, DMSO-d6) δ 4.56 (s, 2H), 7.26 (t, J = 
7.24 Hz, 1H), 7.33 (t, J = 7.36 Hz, 2H), 7.51 (d, J= 7.36 Hz, 2H), 7.59 (d, J= 
7.24 Hz, 1H), 7.75 (s, 1H), 8.24 (d, J= 8.32 Hz, 1H). ESI-MS (m/z) [M]+ 
Calculated: 371.26, found: 371.49 and [M+2H]+ Calculated: 373.26, found: 
373.48 (bromine pattern). 
Analog 17 (ZC-52): 1H NMR (400 MHz, DMSO-d6) δ 0.37 (d, J = 4.12 Hz, 
2H), 0.58 (d, J= 7.2 Hz, 2H), 1.24 (m, 1H), 3.23 (d, J= 7.04 Hz, 2H), 7.58 (d, 
J= 8.12 Hz, 1H), 7.73 (s, 1H), 8.24 (d, J= 8.0 Hz, 1H). ESI-MS (m/z) [M]+ 
Calculated: 335.22, found: 335.52 and [M+2H]+ Calculated: 337.22, found: 
337.55 (bromine pattern). 
Analog 21 or Rbin-6 (AP-38): 1H NMR (400 MHz, DMSO-d6) δ 2.78 (m, 3H), 
4.0 (s, 2H), 4.55 (t, J = 6.66, 2H), 4.91 (s, 1H), 5.14 (s, 1H), 7.48 (t, J = 7.46 
Hz, 1H), 7.75 (t, J = 7.44 Hz, 1H), 7.90 (d, J = 8,24 Hz, 1H), 8.34 (d, J = 7.64 
Hz, 1H). ESI-MS (m/z) [M+H]+ Calculated: 309.40, found: 309.65. 
Analog 22 or Rbin-7 (ZC-21): 1H NMR (DMSO) δ 1.85 (s, 3H), 3.99 (s, 2H), 
4.91 (s, 1H), 5.12 (s, 1H), 7.42 (d, J= 8.4 Hz, 1H), 7.96 (d, J= 8.4 Hz, 1H), 8.59 
(s, 1H). ESI-MS (m/z) [M+H]+ Calculated: 383.22, found: 383.51. 
Analog 23 (ZC-25): 1H NMR (400 MHz, DMSO-d6) δ 4.56 (s, 2H), 7.25 (t, J = 
7.04 Hz, 1H), 7.33 (t, J = 7.32 Hz, 2H), 7.42 (d, J= 8.4 Hz, 1H), 7.51 (d, J = 
7.36 Hz, 2H), 7.96 (d, J= 8.56 Hz, 1H), 8.60 (s, 1H). ESI-MS (m/z) [M+H]+ 
Calculated: 419.26, found: 419.48. 
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CHAPTER 3 
NEGATIVE-STAIN EM STUDIES OF MDN1 
Note to readers: the results discussed below arose from a collaborative effort 
between myself and several colleagues in the Walz Lab at The Rockefeller 
University. In particular, Dr. Hiroshi Suzuki helped me to collect the negative-
stain EM micrographs in this chapter. 
3.1 Introduction 
Members in the AAA protein family feature structurally conserved AAA 
domains that assemble to functional oligomers (Erzberger and Berger, 2006). 
ATP binding and hydrolysis at the ATPase sites, formed by the neighboring 
AAA domains, can drive the conformational changes of individual AAA 
domains and thus the oligomers. The conformational changes of the functional 
oligomers could exert mechanical force to their substrates. Therefore, 
understanding the nucleotide-specific conformations of AAA proteins are key 
to elucidate their cellular functions. 
Mdn1 is required to remodel precursors of 60S subunit of ribosomes in 
the cell. Previous studies identified two ribosome assembly factors, Rsa4 and 
Ytm1, interact directly with the C-terminal MIDAS domain in Mdn1. The 
remodeling function of Mdn1 likely requires conformational coupling between 
the N-terminal AAA domains and the MIDAS domain. However, it has been 
difficult to build models for the coupling mechanism as these two domains are 
separated by more than 2000 aa without known functions. 
Representative 2D averages of negative-stain EM images of Rea1 
(Mdn1 ortholog in S. cerevisiae) revealed that Rea1 forms a ‘ring’ structure 
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with an elongated ‘tail’ and these two parts could adopt different relative 
orientations. The ring structure is likely formed by the AAA domains and the 
tail is comprised of the C-terminal domains. It was assumed that the MIDAS 
domain lies at the tip of the elongated tail. The heterogeneity of orientations of 
the tail relative to the ring was interpreted as a result from the lever-arm 
motions of the tail during Mdn1’s ATPase cycle. However, careful statistical 
analysis of all particles, rather than a few representative averages, is required 
to deduce the distributions of conformational states of Mdn1 particles. 
 In addition, previous negative-stain studies of Rea1 were performed in 
the absence of additional nucleotides and the different 2D class averages 
were interpreted to be various nucleotide-specific conformational states stalled 
during the purification (Ulbrich et al., 2009). However, the heterogeneity of the 
2D projections of Rea1 can be caused by the different viewing angles of the 
particles. Therefore the assignment of specific conformations of Rea1 to 
certain nucleotide states remains an open question. 
3.2 Results: Analysis of S. pombe Mdn1 in the presence of different 
nucleotides, analogs and Rbin-2 
To characterize how the conformations of Mdn1 couple to ATP 
hydrolysis we used negative-stain EM to analyze its structure in the presence 
of different additives, including 1 mM ATP, 1 mM ATP with1 μM Rbin-2, 1 mM 
AMPPNP and 1 mM ADP (Figure 3-1). Representative 2D class averages of 
Mdn1 were generated using Iterative Stable Alignment and Clustering (ISAC) 
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(Yang et al., 2012). These 2D averages revealed that S. pombe Mdn1 is 
comprised of a ‘ring’ and an extended ‘tail’, reminiscent of what was observed 
in the negative-stain EM studies of S. cerevisiae Rea1 (Ulbrich et al., 2009). In 
different 2D averages, the orientations of the tail relative to the AAA ring 
appear to be variable in all conditions. Remarkably, a subset of the averages 
showed six discrete domains within the ring structure (the blue box in Figure 3-
1B), consistent with the presence of six AAA domains in hexameric AAA 
proteins (Erzberger and Berger, 2006). In addition, there appear to be another 
‘ring’ at the tip of the elongated tail in some 2D averages, resulting in a 
dumbbell-like overall shape. Another striking feature observed is that in the 
presence of ADP only, Mdn1’s AAA ring can adopt an ‘open ring’ conformation 
with a gap observed in a subset of the 2D averages (Figure 3-1D). This gap 
locates right next to where the elongated tail extends from the ring, most likely 
between the N-terminal AAA1 domain and the AAA6 domain that connects to 
the C-terminal tail of Mdn1. This conformation would be consistent with a 
hypothesis that loss of ATP binding in the AAA6 ATPase site in Mdn1 causes 
the opening, reminiscent of the opening observed in the AAA1 ATPase site of 
cytoplasmic dynein when crystallized in the absence of nucleotide (Bhabha et 
al., 2014; Carter et al., 2011). The possible interpretations of this gap are 
further discussed below (3.3 Discussion). 
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Figure 3-1. Representative 2D class averages of negative-stain EM 
images of Mdn1 in the presence of different additives. (A-D) 
Representative 2D class averages of Mdn1 in the presence of 1 mM ATP, 
hereafter named as ATP-Mdn1 (A), 1 mM ATP and 1 μM Rbin-2, hereafter 
named as ATPI-Mdn1 (B), 1 mM AMPPNP hereafter named as AMPPNP-
Mdn1 (C) and 1 mM ADP, hereafter named as ADP-Mdn1 (D) resulted from 
Iterative Stable Alignment and Clustering (ISAC). The box size is 460x460 Å. 
Zoom-in views are also shown for two averages in each condition. In (B), a 2D 
average image of ATPI-Mdn1 with six discrete domains (marked by asterisks) 
in the ring structure is highlighted (blue square). In (D), averages of ADP-
Mdn1 with partially opened AAA ring are highlighted (red squares) and the gap 
within the AAA ring is indicated by red triangles in the zoom-in views. 
In order to analyze conformation distributions of all Mdn1 particles on 
grids, 2D classification was performed for all datasets using SPIDER (System 
for Processing Image Data from Electron Microscopy Related Fields) (Shaikh 
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et al., 2008). The lengths of the Mdn1 in the 2D averages were used to 
approximate the lengths of all particles in the corresponding classes. The 
distributions of lengths of Mdn1 were then plotted in histograms (Figures 3-2A 
to D). Overall, there are substantial variations of the lengths of the particles in 
all conditions (12-33 nm). In particular, Mdn1 has a broad distribution of 
lengths in the presence of ATP only (23.5±4.7 nm). The variation is consistent 
with the different viewing angles of different conformations when active ATP 
hydrolysis is allowed in AAA proteins. In comparison, the lengths of Mdn1 in 
the presence of AMPPNP and ADP appear to be shorter and longer, 
respectively, compared to ATP-Mdn1 (Figures 3-2C and D, 21.1±4.2 nm and 
26.2±4.5 nm, respectively), suggesting the additions of AMPPNP and ADP 
may change the conformations of Mdn1 or the distribution of orientations of 
Mdn1 on the EM grids. However, even if AMPPNP and ADP can potentially 
trap the conformation of Mdn1 at specific states, the variations of the length 
distributions in these two conditions suggest that the orientation heterogeneity 
of Mdn1 on grids along can lead to large uncertainties of the lengths. In 
addition, the length distribution of Mdn1 in the presence of ATP and Rbin-2 
(Figure 3-2B) does not appear to be significantly different compared to the 
sample without Rbin-2 (Figure 3-2A). I later found that Rbin-2 only inhibits the 
ATPase activity of Mdn1 in the presence of additional sulfates (2 mM). 
Therefore, I analyzed the distribution of lengths of Mdn1 in the presence of 
ATP and sulfate (2 mM), with or without Rbin-2 (Figures 3-2E and F). 
Variations of lengths in both conditions are similar to other conditions (similar 
standard deviations). However, there appears to be an enrichment of 
extended views of Mdn1 in the presence of Rbin-1 (Figure 3-2E). Together, 
these data suggest that the additions of nucleotides (ADP), nucleotide analogs 
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(AMPPNP) or the chemical inhibitor (ATP-Rbin-2-sulfate) to Mdn1 affect the 
2D averages of Mdn1 on EM grids. 
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Figure 3-2. Length distributions of Mdn1 particles in the presence of 
different additives. (A-D) Length distributions of Mdn1 in the presence of 1 
mM ATP (A), 1 mM ATP and 1 μM Rbin-1 (B), 1 mM AMPPNP (C) and 1 mM 
ADP (D). All particles are classified into 100 classes (k=100) and the length of 
the protein in each 2D average was used to approximate the lengths of all 
particles in that class. The mean and standard deviation of all particles in each 
dataset are also noted. The number of particles in each dataset was also 
shown. Note: all particles were manually picked from the micrographs without 
the bias of shapes except that substantially larger entities, most likely formed 
by more than two Mdn1 molecules, are excluded. (D-E) Length distributions of 
Mdn1 in the presence of 1 mM ATP and 2 mM sulfate (D), and 1 mM ATP, 2 




Together, the negative-stain EM analyses reveal the heterogeneity of S. 
pombe Mdn1’s 2D projections on grids. This heterogeneity can result from the 
convolution of two relevant variations: the variations of Mdn1 conformations 
and the variations of Mdn1 orientations on the EM grids, which are determined 
by the properties of specific conformations. The differences in the length 
distributions of Mdn1 particles in the presence of various additives indicate 
that these additives change the conformations or other important biochemical 
aspects of Mdn1 that affects the orientation of Mdn1 on the EM grids. If not, 
the orientation heterogeneity and the appearance of Mdn1 on grids should 
remain similar. This is consistent with other AAA proteins that association with 
AMPPNP, ADP and ATPase inhibitors can potentially favor specific nucleotide 
states or other properties of Mdn1, e.g. changes the dynamics of residues 
nearby, which affect the orientations of Mdn1. 
The limitation of the two-dimensional analysis is that the lengths of 2D 
averages cannot be directly correlated with the lengths of their corresponding 
conformations in three dimensions. In particular, the variations observed in 
AMPPNP-Mdn1 dataset suggests that there are large uncertainties of the 
orientations even though AMPPNP can inhibit the hydrolysis of ATP by Mdn1 
(as shown in Figure 2-5G) and potentially trap specific conformations. It is 
possible that a particle with short ‘length’ in 2D projections corresponds to an 
extended conformation of Mdn1 that favors a specific orientation on the EM 
grid so that it looks compact in the projection view. Therefore, we cannot 
directly correlate the 2D projections and the conformations of Mdn1.  
S. pombe Mdn1 has a ring-tail configuration similar to Rea1 (the S. 
cerevisiae ortholog). Although differences in the AAA ring cannot be discerned 
66 
in most cases, I observed that in a subset of 2D averages of Mdn1 in the 
presence of ADP only, there exists a gap within the AAA ring, most likely 
between AAA1 and AAA6 domains, reminiscent of the opening observed in 
other AAA proteins in the absence of nucleotide (Carter et al., 2011). These 
results suggest that the loss of ATP in this site can cause the opening for a 
subset of Mdn1 molecules, while the other Mdn1 molecules still have a closed 
AAA ring, most likely due to other unknown redundancy of the interactions 
between AAA1 and AAA6 domains. Interestingly, previous cell-based assay 
indicates that a mutant Mdn1 construct, which has its lysine residue in Walker 
A motif of AAA6 mutated to alanine, can partially rescue the loss of function of 
Mdn1 in cell, consistent with the hypothesis that ATP binding in AAA6 only 
partially contributes to the integrity of the closed-ring conformation of AAA 
domains. However, it is worthy to note that the conformation of wild-type Mdn1 
in the presence of ADP alone may only be relevant in vitro as high 
concentration of ATP (2-5 mM) likely exists in the cellular environment. 
3.4 Methods 
Biochemical preparation of full-length S. pombe Mdn1. 
The full-length S. pombe Mdn1 was prepared as described in Method 
2.5 and used for grids apart from ADP-Mdn1. For ADP-Mdn1, the buffer for the 
size-exclusion chromatography contains 1 mM ADP instead of 50 μM ATP. 
Negative-Stain EM Sample Preparation and Processing.  
The grids for negative-stain were prepared by following a published 
protocol (Ohi et al., 2004). Freshly purified protein was mixed with nucleotides, 
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nucleotide analogs or inhibitor right before the grid preparation. The samples 
were diluted to ~0.01 mg/mL and stained with 0.7% uranyl formate 
(PFALTZ&BAUER, Inc. U01000). The images were then collected at room 
temperature with a Philips CM10 electron microscope equipped with a 
tungsten filament operating at 100 kV. All images were recorded on an AMT 
XR16L-ActiveVu charge-coupled device camera (Woburn, MA, USA) using a 
defocus of approximately -1.5 μm and a nominal magnification of 52000x.  
Manual particle picking was performed using Boxer in EMAN and 
windowed into 216 x 216-pixel images (Tang et al., 2007). The particle images 
were then reduced to 64 x 64-pixel boxes. 2D classification was then 
performed using iterative stable alignment and clustering (ISAC) algorithm 
(Yang et al., 2012). Five iterations were performed using a ‘threshold’ of 0.07 
and an ‘initial number of particles per group’ as 100.  
System for processing image data from electron microscopy related 
fields (SPIDER) was also used to analyze the same datasets. In particular, all 
particles in each dataset are classified to 100 classes (k=100) using reference-
free alignment for 10 iterations. The 2D class averages of the last iteration 
were then analyzed in Photoshop. The maximum 1D dimensions of the 
averages were assigned to the lengths of all particles in the class. 
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CHAPTER 4 
Cryo-EM studies of S. pombe Mdn1 in the presence of AMPPNP 
Note to readers: the results discussed below arose from a collaborative effort 
between myself and several colleagues in the Kapoor Lab and the Walz lab at 
The Rockefeller University. A closely related version is in press in Cell 
(DOI:10.1016/j.cell.2018.09.015). In particular, Dr. Hiroshi Suzuki provided 
help in building the models in this chapter.  
4.1 Introduction 
While the negative-stain studies of S. pombe Mdn1 constitute a step 
toward the understanding of its domain architecture, the limited resolution 
does not allow us to assign individual domains for this large protein, such as 
the MIDAS domain, let alone understand the coupling between domains. In 
addition, the heterogeneity of 2D averages of negative-stain images can result 
from the combination of both conformational heterogeneity and orientational 
heterogeneity on grids. Therefore, high-resolution three-dimensional structural 
analysis of Mdn1 is required to understand Mdn1’s function during ribosome 
biogenesis. 
4.2 Cryo-EM structure of Mdn1 in the presence of AMPPNP 
Full-length S. pombe Mdn1 has the N domain, six AAA, linker, D/E-rich 
and MIDAS domains in a single polypeptide (aa 1-4717, Figure 4-1A). To 
reduce the potential conformational heterogeneity of Mdn1, the full-length S. 
pombe Mdn1 was incubated with AMPPNP (1 mM), a nucleotide analog that 
inhibits the ATPase activity of recombinant Mdn1 (Figure 2-5G) and analyzed 
using single-particle cryo-EM (Appendix Figure 4-1). Initial class averages 
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indicated that Mdn1 adopts an elongated structure with a hexagonal ‘ring’ 
(Figure 4-1B, filled arrowhead), an arrangement of AAA domains typical for the 
proteins in the superfamily (Erzberger and Berger, 2006; Hanson and 
Whiteheart, 2005), connected to an elongated, hook-shaped ‘tail’ (Figure 4-1B, 
empty arrowhead), similar to the negative-stain averages of Mdn1 (Figure 3-
1).  
Three-dimensional (3D) classification of Mdn1 particles indicated that 
the ring and tail densities varied slightly in their relative orientations, likely due 
to flexibility at a single site in the tail, which we named ‘hinge point’ (Figure 4-
1C, red arrowheads, see Appendix Figure 4-1B for details). Therefore, we 
masked the densities for the ring and tail regions, above and below the hinge 
point, in Mdn1 and processed them separately. The final 3D maps were 
refined to an estimated resolution of 4.0 Å for the ring region, and 5.9 Å for the 
tail region (Figure 4-1C, Appendix Figures 4-1C and 4-2A). At 4.0 Å resolution, 
α-helices and individual β-strands can be resolved in Mdn1’s ring region 
(Figure 4-1C and Appendix Figure 4-2C). We were also able to trace the 
backbone for the N-terminal portion, which included the N and AAA domains 
and the tail up to the hinge point (Figure 4-1C). A pseudo-atomic model for the 
AAA domains was built based on known AAA protein folds (Erzberger and 
Berger, 2006). The remaining tail density was modeled with polyalanine 
helices. Hereafter, we refer to this model as AMPPNP-Mdn1. 
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Figure 4-1. Overall architecture of full-length Mdn1 in the presence of 
AMPPNP. (A) Schematic for the domain organization of S. pombe Mdn1 (aa 1-
4717). Residue numbers at selected domain boundaries are indicated. (B) 
Selected class averages of vitrified Mdn1 in the presence of AMPPNP (1 mM). 
The AAA ring (filled arrowhead) and the hook-shaped tail (open arrowhead) 
are indicated. (C) Two views of the Mdn1 density map (grey surface) with the 
model that was built into the map (ribbon representation, colored as in (A)) 
(hereafter, AMPPNP-Mdn1). The model and a schematic for the N, AAA and 
linker domains are shown. The hinge point (red arrowhead) in the tail region, 
where the density was split and processed separately, is also indicated in the 
model. 
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The AAA ring of AMPPNP-Mdn1 has an outer diameter of ~140 Å, an 
inner diameter of ~30 Å and a height of ~65 Å. The elongated tail region is 
composed of five bundles of α-helices. The tail first extends from the AAA ring 
for ~20 nm but then turns back to form a hook-like structure. The angle 
between the base of the tail and the plane of the AAA ring is ~120° (Figure 4-
1C). The model for the hook-shaped tail accounts for ~1400 amino acids, 
which includes ~50% of the C-terminal residues after the AAA domains (~2600 
aa, Figure 4-1A), suggesting that a portion of the C-terminal tail domain may 
be disordered. 
We next examined the organization of the six AAA domains in Mdn1. In 
general, each AAA domain is comprised of a large N-terminal subdomain 
(AAA-L) and a small C-terminal subdomain (AAA-S) (Figure 4-2A). Six AAA-L 
and five AAA-S subdomains could be readily identified in the cryo-EM map as 
they adopt characteristic folds of AAA domains (Figures 4-2B to G) (Erzberger 
and Berger, 2006). 
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Figure 4-2. Density map of individual AAA domains in AMPPNP-Mdn1 
with models. (A) Schematic of secondary-structure elements of two 
sequential AAA domains and the arrangement of their subdomains. α-Helices 
(grey cylinders) and β-strands (yellow arrows) are shown. The N and C termini 
of the first AAA domain (solid red linkers) and those of the second AAA domain 
(faded red linkers) are shown. The dashed box indicates rigid body i, which is 
formed by subdomains AAAi-S and AAA(i+1)-L. Helices 0 (H0), 1 (H1) and 2 
(H2) are the first three helices in the large subdomain. The H2 insertions, 
which are present in all six AAA-L domains of Mdn1 but have different lengths 
(15-120 aa), are represented as green rectangles. The aromatic motif at the 
beginning of H2 helix is also labeled (blue bar). These motifs are also labeled 
in the alignment of Mdn1 orthologs’ sequences in Figure 1-4. (B-G) The 
density map of each AAA domain (grey mesh) is shown with the built model 
(ribbon representation). The nucleotides (stick representation) bound between 
the large and small subdomains of AAA1-4 and next to the AAA6-L subdomain 
are shown. All nucleotide densities are modeled as AMPPNP molecules. Note 
that AAA5 shows no density for a nucleotide. 
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In the orientation shown in the left panel of Figure 4-3A, the AAA-L 
domains are at the lower face of the ring, while the AAA-S domains lie above. 
The polypeptide chain following the C terminus of AAA6-L, which was 
expected to form the AAA6-S domain, lacks structural similarity to other AAA-
S domains within Mdn1. We find that this region of the protein extends out of 
the ring and forms the base of the linker domain (Figure 4-3A). The N, AAA1-L 
and AAA6-L domains form a structural motif, which we name the ‘ring-linker 
junction’, that establishes the orientation of the hook-shaped linker domain 
relative to the AAA ring (Figure 4-3A). The formation of this ring-linker junction 
covers multiple interfaces between the N, AAA1-L, AAA6-L and linker domains 
and also the nucleotide bound in the AAA6 ATPase site.  
Sequence alignments reveal that Mdn1 belongs to a subfamily of AAA 
proteins that possess insertions following helix H2 in the AAA-L subdomain 
(called H2 insertion, green box in Figure 4-2A and sequence alignment in 
Figure 1-4) (Erzberger and Berger, 2006). For three AAA-L subdomains 
(AAA1-L, AAA3-L, and AAA5-L), these insertions are <20 amino acids, while 
the other AAA-L subdomains (AAA2-L, AAA4-L and AAA6-L) have longer 
insertions (60-120 aa, Figure 4-3A and sequence alignment in Figure 1-4). We 
find that all the long H2 insertions project out from the same face of the AAA 
ring, opposite to that from which the tail extends (Figure 4-3A). The AAA2 H2 
insertion (120 aa) forms a four-helix bundle that is proximal to the central hole 
of the AAA ring (Figure 4-3A). The AAA4 H2 insertion (60 aa) contains a 
bundle of three helices. Finally, the AAA6 H2 insertion (~100 aa) is also 
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largely helical and adjoins the AAA6-L and AAA1-L domains (Figure 4-3A), 
possibly functioning as a bridging element.  
Figure 4-3. Asymmetric arrangement of six AAA domains in Mdn1. (A) 
Two views of the model for the six AAA domains and part of the linker domain, 
along with a schematic, are shown. The AAA ring core (dashed rectangle) is 
highlighted. (B-E) Alignment of the AAA2-5 domains with the AAA1 domain 
using their large subdomains. In (E), an ~40º difference between the 
orientations of the small subdomains in AAA5 and AAA1 is apparent. (F) AAA1 
and AAA5 small subdomains viewed from the direction indicated by the red 
arrow in (E).  Differences in the positions of the five equivalent α-helices (black 
arrows) are highlighted. (G and H) Surface representations of the AAA1 (G) 
and AAA5 (H) domains. In (G), the nucleotide (sphere representation) is also 
highlighted.  
We note that the AAA1 and AAA6 in S. pombe Mdn1 lack the “Asp-Glu” 
Walker B motif that is required for ATP hydrolysis in AAA proteins (sequence 
alignment in Figure 1-4) (Erzberger and Berger, 2006), suggesting that 
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ATPase activity in Mdn1 is restricted to its AAA2-5 ATPase sites. Consistent 
with this hypothesis, cell-based studies have shown that key residues in the 
Walker A, Walker B and arginine finger motifs in the AAA2-5 ATPase sites are 
all required for Mdn1 function (Kawashima et al., 2016). We next compared 
the relative orientations of the five AAA-L and associated AAA-S subdomains 
(Figures 4-3B to E). AAA6 is not included as it lacks a typical AAA-S 
subdomain. The small and large subdomains in AAA2 to AAA4 show a similar 
arrangement as seen in AAA1 (Figures 4-3B to D). In AAA5, however, the 
small subdomain is rotated by ~40° relative to its large subdomain, causing 
substantial displacements of the five α-helices in AAA5-S (Figures 4-3E and F). 
This difference in relative orientation results in an opening between the small 
and large subdomains in AAA5 (Figures 4-3G and H). 
Interestingly, we can assign densities corresponding to nucleotides in 
the AAA1-AAA4 and AAA6 ATPase sites but not in the AAA5 site (Figures 4-
2B to G). As the cell-based studies indicate that ATP hydrolysis at the AAA5 
ATPase site is needed for Mdn1 function, we expected that AAA5 contributes 
to Mdn1’s overall ATPase activity. To test this we expressed and purified a 
construct with a Walker B mutation in Mdn1’s AAA5 domain (E1637Q). 
Equivalent mutations have been used to disrupt ATP hydrolysis but not ATP 
binding in AAA proteins (Bhabha et al., 2014; Martin et al., 2005). The AAA5 
mutant protein eluted from a size-exclusion column at 10.6 mL, similar to wild-
type Mdn1 (elution volume: 10.6 mL) (Figures 4-4A and B). Negative-stain EM 
analysis revealed that the AAA5 mutant adopts an extended conformation, 
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with the ring and tail regions appearing similar to those observed for wild-type 
Mdn1 (Figure 4-4C). We found that the ATPase activity of the mutant construct 
is 0.15±0.02 ATP per second (Figure 4-4D), which is ~15% of what we 
measured under similar conditions for wild-type Mdn1 (Kawashima et al., 
2016). Addition of Rbin-1 (1 μM) inhibited ~40% of the ATPase activity of the 
mutant, similar to what we observed for wild-type Mdn1 at this inhibitor 
concentration (Kawashima et al., 2016). These data are consistent with Rbin-1 
targeting a site in Mdn1 other than the AAA5 ATPase site and with the 
observed ATPase activity being mainly due to the mutant Mdn1 construct. 
Together, our findings suggest that the AAA5 site contributes to Mdn1’s overall 
ATPase activity and that the ATPase sites are structurally asymmetric and 
likely function asynchronously. 
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Figure 4-4 Characterization of AAA5 Walker B mutant Mdn1 (E1637Q-
Mdn1). (A) Size-exclusion chromatography profile for E1637Q-Mdn1 (AAA5 
mutant) (elution volume: 10.6 mL, void 7.5 mL). (B) SDS-PAGE analysis of 
purified E1637Q-Mdn1 (Coomassie blue stain). (C) Negative-stain EM image 
of Mdn1 carrying the E1637Q mutation in the Walker B motif of AAA5. Scale 
bar: 20 nm. (D) ATPase activities of Mdn1 in the presence of solvent control 
(DMSO) and Rbin-1 (1 μM, dissolved in DMSO) were measured using an 
NADH-coupled ATPase assay ([MgATP] = 1 mM). 
4.3 Cryo-EM structure of Mdn1-ΔC in the presence of AMPPNP 
Although sequences of individual domains of N-terminal portion (aa 1-
2109) of Mdn1 can be assigned to specific densities in the ring region of 
AMPPNP-Mdn1 map, the identities of sequences represented by the tail 
region of the same map are still unclear. In particular, only ~1400 aa is 
required to explain the densities of helical bundles in the hook-shaped tail 
(purple model in Figure 4-1C), indicating more than 1000 aa of the C-terminal 
sequence (aa 2110-4717) is not observed. 
Secondary-structure prediction algorithms suggest that the ~500 aa-
long D/E-rich domain, which follows the linker domain, likely contains only two 
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α-helices (formed by ~30 amino acids) and no β-strands (see secondary 
structure predictions in Figure 1-4). To test if the D/E-rich domain is indeed not 
observed in the map, I generated and purified an Mdn1 construct that lacked 
the D/E-rich and MIDAS domains (Mdn1-ΔC, aa 1-3911) (Figures 4-5A to C). I 
first used negative-stain EM to analyze the conformation of this truncated 
Mdn1 in the presence of AMPPNP. Two-dimensional class averages revealed 
a ring with a hook-shaped tail (Figure 4-5D), similar to the 2D class averages 
of the full-length Mdn1. Furthermore, the three-dimensional density map of 
AMPPNP-Mdn1 can be oriented to recapitulate these 2D projections of Mdn1-
ΔC (Figure 4-5E). I then used single-particle cryo-EM to determine the 
structure of Mdn1-ΔC in the presence of AMPPNP. Maps at a resolution of 6.5 
Å for the region including the AAA ring and 7.4 Å for the rest of the protein 
were obtained (Figures 4-5F and G, and Appendix Figure 4-3). The AMPPNP-
Mdn1-ΔC map reveals a hexagonal ring and hook-shaped tail similar to the 
AMPPNP-Mdn1 map (Figure 4-5G). In addition, the model for full-length Mdn1 
could be placed into the density map of Mdn1-ΔC as a single rigid body 
without further adjustment (Figure 4-5G). Together, these data indicate that 
the hook-shaped tail is formed by the linker domain alone (Figure 4-5G) and 
also confirm that the D/E-rich and MIDAS domains are not observed for the 
full-length Mdn1 map (Figure 4-1C). Further, these data also suggest that 
removal of the C-terminal D/E-rich and MIDAS domains does not affect the 
overall structure of the AAA and linker domains in the presence of AMPPNP. 
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Figure 4-5. Purification and Cryo-EM analysis of Mdn1-ΔC in the 
presence of AMPPNP. (A) Schematic of the Mdn1-ΔC construct that lacks the 
C-terminal D/E-rich and MIDAS domains (amino acids 1-3911). (B) Size-
exclusion chromatography profile for Mdn1-ΔC (elution volume: 11.5 mL). The 
elution volumes of the void peak (7.5 mL) and full-length Mdn1 (Mdn1-FL, 10.6 
mL) are also indicated for comparison. (C) Peak fractions from the size-
exclusion chromatography of Mdn1-ΔC and Mdn1-FL were analyzed by SDS-
PAGE (Coomassie stain). (D) Representative 2D class averages of Mdn1-ΔC 
in the presence of AMPPNP. The AAA ring (filled arrowhead) and the hook-
shaped tail (open arrowhead) are indicated. (E) The cryo-EM map for 
AMPPNP-Mdn1 is oriented at similar viewing angles as seen in the 2D 
averages in (D). The AAA ring (filled arrowhead) and the hook-shaped tail 
(open arrowhead) are indicated. Note that the hook-shaped tail appears to be 
a ring (dashed oval) from certain viewing angles in both (D) and (E). (F) 
Selected class averages of vitrified Mdn1-ΔC in the presence of AMPPNP (1 
mM). Note that the hook-shaped tail is discernible in some class averages 
(open arrowhead). (G) Two views of the EM density map of Mdn1-ΔC (yellow 
surface). The Mdn1 model for full-length Mdn1 (the same model shown in 
Figure 4-1C, blue for the ring region and purple for the tail region) could be 




In summary, cryo-EM structures of full-length and truncated S. pombe 
Mdn1 in the presence of AMPPNP provided high-resolution structural insights 
for Mdn1 in three dimensions. In particular, the pseudo-atomic model for the 
N-terminal portion of Mdn1 revealed an asymmetric AAA ring with H2 
insertions extending from one side of the AAA ring, opposite to the side to 
which the tail of helical bundles extends. The models also revealed the domain 
architecture of the C-terminal portion of Mdn1. 
S. pombe Mdn1 has Walker A motifs in all of its six AAA ATPase sites. 
In the presence of 1 mM AMPPNP, densities corresponding to nucleotides are 
observed in five out of six interfaces between neighboring AAA domains, 
leaving AAA5 site empty. Still, the hydrolysis of AAA5 appears to be important 
for the overall ATPase cycle of Mdn1. A single-point Walker B mutation (E to 
Q) in AAA5 reduces the ATPase activity of Mdn1 to ~15% of the wild-type
Mdn1. As Rbin-1 inhibits ~40% of the wild-type and AAA5 mutant Mdn1’s 
ATPase activities, it is likely that Rbin-1 blocks the activity at sites other than 
AAA5. Therefore, we suggest that AAA5 alone does not contribute to ~85% of 
Mdn1’s overall ATPase activity. Studies of AAA proteins have revealed 
functional coupling between different AAA ATPase sites (Bhabha et al., 2014; 
DeWitt et al., 2015). We propose that similar to dynein’s AAA3 domain, which 
can allosterically regulate the ATPase activity at AAA1, the nucleotide states 
of Mdn1’s AAA5 domain modulate the ATPase activity at other AAA sites 
(Bhabha et al., 2014; DeWitt et al., 2015).  
83 
One unexpected structural feature of Mdn1 is the lack of AAA6-S 
subdomain in Mdn1, in contrast to other AAA proteins. However, the AAA ring 
appears to be closed at the interface between AAA1 and AAA6 domains in the 
ring-linker junction. In particular, the N-domain and the H2 insertion of AAA6 
interact with both AAA1-L and AAA6-L subdomains, functioning as the bridges 
to close the AAA ring. The presence of nucleotide within the AAA6 ATPase 
site may also favor the closed interface, as nucleotide binding in the AAA1 
ATPase site in dynein leads to closed interface between the AAA1 and AAA2 
domains. These analyses are also consistent with the observation that the loss 
of the ATP binding in the AAA6 site only lead to open ring conformation in a 
subset of the molecules in the negative-stain analysis of ADP-Mdn1 sample 
due to the redundancy of interaction at this interface.  
The linker domain in S. pombe Mdn1 (aa 2110-3911), which contains 
1802 residues without good homology to well-studied proteins, forms multiple 
helical bundles. Our alanine-helices model of the hook-shaped tail contains 
1334 residues, suggesting there are 468 amino acids of the linker domain 
missing in our model. Secondary structure prediction of the linker domain in S. 
pombe Mdn1 suggests there are 500 out of 1802 residues (aa 2110-3911) 
without well-defined secondary structures between multiple α-helices (Figure 
1-4), consistent with a hypothesis that a substantial portion of the missing 
residues are involved in the formation of the loops that are not modeled 
between the ~50 α-helices. These analyses also suggest the linker domain is 
unlikely to form other large and well-defined structure in addition to the hook-
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shaped tail and this information is helpful to assign unknown densities in other 
states (see Chapter 5). In addition, sequence comparisons of Mdn1 orthologs 
reveal that the conservation of the linker domain is only moderate (Table 4-1). 
In particular, conserved hydrophobic residues are arranged three or four 
residues apart (i, i+3 or i+4), consistent with the helical bundle structure (see 
sequence alignment in Figure 1-4). These analyses suggest that a substantial 
part of the linker domain may function as a structural unit by forming helical 
bundles. However, this cannot exclude that certain regions of the linker 
domain may still be important for specific functions of Mdn1. 
Table 4-1. Comparisons of individual domains in S. pombe Mdn1 and S. 
cerevisiae Mdn1 (Rea1). 
S. pombe Mdn1 S. cerevisiae Mdn1 Sequence Identities 
AAA 1979 aa 2030 aa 49% 
Linker 1802 aa 1745 aa 18% 
D/E-rich 517 aa 566 aa 24% 
MIDAS 289 aa 284 aa 55% 
Our results also suggest that the tether between the MIDAS and linker 
domains, i.e. the D/E-rich domain, adopt multiple conformations in the full-
length Mdn1 in the presence of AMPPNP.  The flexibility of D/E-rich domain is 
consistent with the secondary structure prediction based on the amino acid 
composition. In particular, the abundant negatively charged residues (Asp/Glu 
for 182 out of the 516 aa, >35%) would disfavor compact and well-defined 
folds, resulting in a flexible polypeptide. Interestingly, although the amino acids 
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composition of D/E-rich domains of Mdn1 orthologs are similar (>30% are 
Asp/Glu), the sequence identity of this domain is only moderate (Table 4-1), 
suggesting that evolution constrained the bias of the amino acid composition 
but not the exact positions of the negatively-charged residues. This is 
consistent with an idea that the D/E-rich domain has evolved to be a flexible 
polypeptide. 
The flexibility of ~500 aa D/E-rich domain would disfavor the previously 
proposed lever-arm mechanism that is reminiscent of the powerstrokes of 
motor proteins like myosin or dynein (Bhabha et al., 2014; Spudich, 2001) 
since the flexible domain may not transmit force efficiently from the N-terminal 
AAA ring to the C-terminal MIDAS domain. In addition, the alternative 
hypothesis, i.e. the conformation communication between the AAA ring and 
the MIDAS domain through the entire tail in Mdn1, similar to the conformation 
coupling between the AAA domains and the microtubule-binding domain 
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through the structured coiled-coil stalk in dynein, is also unlikely due to the 
flexibility of the D/E-rich domain. 
4.5 Methods 
Biochemical preparation of full-length S. pombe Mdn1 and Mdn1-ΔC. 
The full-length S. pombe Mdn1 and Mdn1-ΔC were prepared as 
described in Method 2.5. 
Negative-Stain EM Sample Preparation and Processing. 
The grids of Mdn1-ΔC were prepared and the micrographs were 
collected as described in Method 3.4. The data was processed using ISAC as 
in Method 3.4. 
NADH-coupled steady-state ATPase assay.  
For each steady-state ATPase reaction, the final volume was 25 μL. The final 
concentration of E1637Q-Mdn1 (AAA5 Walker B mutant) was ~40 nM. Sodium 
sulfate, NADH (Sigma N7410), phosphoenol pyruvic acid monopotassium salt 
(Sigma P7127), D-lactic dehydrogenase (Sigma L3888) and pyruvate kinase 
(ammonium sulfate suspension, Sigma P1506) were added to final 
concentrations of 2 mM, 200 μM, 1.0 mM, 30 U/mL and 30 U/mL, respectively. 
The presence of 2 mM sodium sulfate enhances inhibition of Mdn1’s ATPase 
activity by Rbins. 1 μl DMSO or compound dissolved in DMSO was added and 
mixed. 5 μl 5 mM MgATP (pH = 7.0), was added to make the final total volume 
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to be 25 μl and the final concentration of MgATP to be 1 mM. Time course of 
fluorescence (440 nm) decrease due to NADH oxidation was measured using 
a Synergy NEO Microplate Reader. The fluorescence values were plotted 
against time and fit by linear regression. The slopes of these lines were used 
to calculate the ATPase rate. 
Cryo-EM sample preparation and data collection. 
To prepare cryo-EM grids of full-length Mdn1 with AMPPNP and Mdn1-
ΔC with AMPPNP, the purified protein was concentrated to ~0.15 mg/mL 
using centrifugal filters (MW cutoff: 50 kDa; Millipore) and mixed with 10x 
AMPPNP stock solution (final concentration: 1 mM AMPPNP). To minimize the 
potential hydrolysis of AMPPNP, AMPPNP was added to Mdn1 immediately 
before the grids were frozen (<10 min). Samples were applied to Quantifoil 
R1.2/1.3 400 mesh Au holey carbon grids (Quantifoil), blotted and plunge-
frozen in liquid ethane using a Vitrobot Mark IV (Thermo Fisher Scientific). 
Cryo-EM data were collected on a 300-kV Titan Krios electron microscope 
(Thermo Fisher Scientific) equipped with a K2 Summit detector at a nominal 
magnification of 22,500x in super-resolution counting mode. After binning over 
2 x 2 pixels, the calibrated pixel size was 1.3 Å on the specimen level. 
Exposures of 15 s were dose-fractionated into 50 frames with a dose rate of 
10 electrons pixel-1 s-1, resulting in a total dose of 88.8 electrons Å-2. Defocus 
values ranging from -1.4 to -3.0 μm were used. Cryo-EM data collection 
statistics can be found in Table 4-1. 
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The data processing is summarized in Table 4-2. All movie frames were 
corrected with a gain reference collected in the same EM session, and 
specimen movement was corrected using MotionCor2 with dose weighting 
(Zheng et al., 2017). Images showing substantial ice contamination, abnormal 
background, thick ice or low contrast were discarded. The contrast transfer 
function (CTF) was estimated using CTFFIND4 (Rohou and Grigorieff, 2015). 
Approximately 10,000 particles were manually picked, subjected to 2D 
classification, and the resulting averages were used as templates for 
automatic particle picking using Gautomatch (http://www.mrc-
lmb.cam.ac.uk/kzhang/Gautomatch/). In particular, six representative 2D 
averages were rotated every 30° over 360° to generate seventy-two 2D views 
and then used as templates in Gautomatch. Particles selected for all 
micrographs were visually inspected, and poorly selected particles were 
manually adjusted or discarded. The final datasets for AMPPNP-Mdn1 and 
AMPPNP-Mdn1-ΔC contained 398,829 and 217,779 particles, respectively. 
For AMPPNP-Mdn1, an initial pilot dataset containing 60,632 particles 
(box size: 300 x 300 pixels) was subjected to 2D classification using RELION 
1.4 (Appendix Figure 4-1B). Classes that produced poor averages were 
discarded. Subsequent 3D classification into five classes was carried out in 
RELION 2.0, using the ATPI-Mdn1 map filtered to 25 Å as the initial reference. 
The resulting class averages differed slightly in the angle between the ring 
region (up to the hinge in the tail) and the rest of the tail. The class average 
showing the clearest structural features was further refined, resulting in a 
Cryo-EM data processing.  
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density map at ~8.0 Å resolution (FSC = 0.143). This map was used to 
generate generous masks for the entire protein, the ring region, and the tail 
region. The full dataset containing 398,829 particles was processed using 
RELION 2.0 (Appendix Figure 4-1C) (See Table 4-2 for statistics for 
processing the complete dataset). All particles after 2D clean-up (313,336 
particles) were first refined against the final map obtained from the pilot 
dataset filtered to 25 Å resolution using the mask for the entire protein. Then, 
3D classifications into six classes for the ring region and eight classes for the 
tail region were performed separately, using the local search option and the 
respective masks. In both cases, the best-resolved class accounts for ~30% of 
the total number of particles. Refinement of the best class for the ring region 
(containing 87,580 particles) produced a map at ~4.4 Å resolution, and 
refinement of the best class for the tail region (containing 94,649 particles) 
yielded a map at ~5.3 Å resolution (FSC = 0.143). We observed that the FSC 
curve for the tail region approached the 0.143 level (at ~5.9 Å) but then 
increased abruptly again before crossing the 0.143 level at a later point (at 
~5.3 Å) (Appendix Figure 4-2A). This map was low-pass filtered to 5.9 Å and 
used in figures. The map of the ring region after post-processing was used as 
the reference for refinement of all particles after 2D clean-up (313,336 
particles) in FREALIGN (Grigorieff, 2016), yielding the final map at a resolution 
of ~4.0 Å (FSC = 0.143) (Appendix Figure 4-2A). Local-resolution maps of the 
ring and tail regions of AMPPNP-Mdn1 were calculated by ResMap in RELION 
2.0 (Appendix Figures 4-2B and F). These local-resolution maps represent 
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relative differences in resolution across the maps but the absolute values may 
not be exact. 
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Table 4-2. Cryo-EM Data Collection and Reconstruction Statistics of 














 Microscope Titan Krios 
 Detector K2 Summit 
 Pixel size (Å) 1.3 
 Voltage (kV) 300 
 Total electron exposure (e–Å-2) 88.8 
 Defocus range (μm) -1.4 to -3.0 
Reconstruction (RELION) 
 Particle number 87,580 94,649 21,164 22,921 
 Box size (pixels) 300 300 300 300 
 Resolution (Å) (FSC = 0.143) 4.4 5.3 6.1 7.4 
 B-factor (Å2) -171 -211 -161 -178 
Reconstruction (FREALIGN) 
 Particle number 313,336 
 Box size (pixels) 300 
 Resolution (Å) (FSC = 0.143) 4.0 
 B-factor (Å2) -175 
The AMPPNP-Mdn1-ΔC dataset was processed similarly as the full 
dataset of AMPPNP-Mdn1 in RELION 2.0 (Appendix Figure 4-3) (See Table 4-
2 for statistics for processing the complete dataset). All particles after 
autopicking (217,779 particles, box size: 300 x 300 pixels) were subjected to 
2D classification. Classes generating poor averages were discarded, and the 
remaining 175,881 particles were refined to the AMPPNP-Mdn1 map filtered to 
25 Å resolution using the mask for the entire protein. 3D classifications into 
five classes using the local search option were carried out separately for the 
ring and tail regions with the respective masks. Refinement of the best class 
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for the ring region (containing 26,164 particles) produced a map at ~6.1 Å 
resolution, and refinement of the best class for the tail region (containing 
22,921 particles) yielded a map at ~7.4 Å resolution (FSC = 0.143) (Appendix 
Figure 4-3F). We observed the FSC curve for the ring region approached the 
0.143 level (at ~6.5 Å) but then increased abruptly again before crossing the 
0.143 level at a later point (at ~6.1 Å) (Appendix Figure 4-3F). This map was 
low-pass filtered to 6.5 Å and used in figures. Local-resolution maps of the ring 
and tail regions of AMPPNP-Mdn1-ΔC were calculated by ResMap in RELION 
2.0 (Appendix Figure 4-3G). These local-resolution maps represent relative 
differences in resolution across the maps but the absolute values may not be 
exact. 
Model building and refinement.  
The structural model for AMPPNP-Mdn1 was built in three steps: first 
the AAA domains were built without the flexible loops and H2 insertions, then, 
the linker domain, and finally the N domain, loops and H2 insertions. Phyre2 
was used to calculate initial homology models of the AAA domains (Kelley et 
al., 2015). Flexible loops, as well as the H2 insertions, were removed from the 
homology models, and the AAA domains were split into their large and small 
subdomains. These subdomains were fit into the ring region of the ~4.0 Å 
resolution AMPPNP-Mdn1 map using Chimera (Pettersen et al., 2004). Since 
most side chains were not resolved in the cryo-EM density map, we removed 
all side chains beyond the β-carbons using the phenix.pdbtools command in 
PHENIX (Adams et al., 2010). The β-carbons and sequence information was 
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preserved to constrain further refinement using the phenix.real_space_refine 
command in PHENIX with morphing, simulated annealing and secondary 
structure restrains.  
For the density of the hook-shaped tail in AMPPNP-Mdn1, α-helical 
segments were first identified using the phenix.find_helices_strands command 
in PHENIX. Polyalanine α-helices were built into the density, which accounted 
for most, if not all, of the tail density. Guided by the secondary structure 
predictions from SPIDER2 (Yang et al., 2017) and PSIPRED (Buchan et al., 
2013), we were able to trace the backbone and to establish the connectivity of 
the α-helices from the C-terminal end of the AAA6-L domain up to the hinge. 
Due to the ambiguity in the helical registry, we only built a polyalanine model 
for the traced backbone. For the cryo-EM map of the rest of the tail, i.e., the C-
terminal density after the hinge, which was masked and refined separately and 
resolved at ~5.9 Å resolution, we used the identified polyalanine helices 
without connecting loops to present the overall architecture of the helical 
bundles (as shown in Figure 4-1C).  
For the N domain, loops and H2 insertions, we first combined the 
models of the AAA domains (the backbone model with β-carbons) and the 
linker domain up to the hinge (the polyalanine model) and then focused on 
unassigned densities for the ring region of AMPPNP-Mdn1 map. Ab initio 
model building for the N domain, loops and H2 insertions was carried out in 
COOT (Emsley et al., 2010), guided by secondary-structure predictions. For 
regions in which bulky side chains were resolved as bumps (as shown in 
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Appendix 4-2C), we used these residues as anchor points during model 
building. Further refinement using the phenix.real_space_refine command in 
PHENIX with secondary structure restrains and manual adjustments in COOT 
were performed iteratively, yielding our final model for the N-terminal density. 
For model validation, the final model for the N-terminal region (up to the hinge) 
was refined against one of the independent half maps (work) of the 
corresponding ~4.0 Å resolution map. FSC curves were then calculated 
between the refined model and half map 1 (work), half map 2 (free) as well as 
the combined map (Appendix Figure 4-2E).  
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CHAPTER 5 
CRYO-EM STUDIES OF MDN1 IN THE PRESENCE OF ATP AND RBIN-1 
Note to readers: the results discussed below arose from a collaborative effort 
between myself and several colleagues in the Kapoor Lab and the Walz lab at 
The Rockefeller University and Kawashima lab at The University of Tokyo. A 
closely related version is in press in Cell (DOI:10.1016/j.cell.2018.09.015). In 
particular, Dr. Hiroshi Suzuki and Dr. Frank Dimaio provided help in building 
the models in this chapter. Dr. Shigehiro Kawashima and Dr. Yuki Kobayashi 
performed the yeast complementation assay.  
5.1 Introduction 
The structures of AMPPNP-Mdn1 revealed the domain organization of 
this large protein but could not resolve the position of the MIDAS domain, 
which is known to interact with other ribosome assembly factors, such as Rsa4 
and Ytm1. Therefore, the coupling between the AAA and the MIDAS domains, 
or in other words, the coupling between the ATPase cycle of Mdn1 and Rsa4, 
remains an open question. In order to understand Mdn1’s remodeling function 
during ribosome biogenesis, we set out to examine other potential nucleotide 
states of Mdn1. 
5.2 Cryo-EM structure of Mdn1 in the presence of ATP and Rbin-1 
We next examined the potential conformational changes of Mdn1 
during ATP hydrolysis by determining the cryo-EM map of Mdn1 in the 
presence of ATP (1 mM) and Rbin-1 (1 μM) (Kawashima et al., 2016). Two-
dimensional class averages revealed an elongated structure similar to that of 
AMPPNP-Mdn1 (Figure 5-1A). 3D classification of the entire molecule yielded 
a class with well-defined density for both the ring and tail regions. The final 
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density map was refined to a resolution of 7.7 Å (Figure 5-1B and Appendix 
Figure 5-1, hereafter named ATPI-Mdn1), with α-helices and β-sheets, but not 
individual β-strands, readily distinguishable. 
We found that the maps revealed similar overall organizations for ATPI- 
and AMPPNP-Mdn1 (Figures 5-1A to C). For the N-terminal region of ATPI-
Mdn1, up to the hinge in the linker domain, we could build a backbone model 
using the AMPPNP-Mdn1 model (multicolored ribbons in Figure 5-1B). 
Nucleotides, Rbin-1 and the H2 insertions of AAA2 and AAA4 could not be 
readily assigned. Interestingly, ATPI-Mdn1 also has its tail oriented ~120° 
relative to the AAA ring (left panel in Figure 5-1B), as observed in AMPPNP-
Mdn1 (Figure 4-1C). Overlaying the ‘ring-linker junction’ from these two 
structures also did not reveal substantial differences (Figure 5-1D). In addition, 
the poly-alanine model for the entire hook-shaped tail from AMPPNP-Mdn1 
could be placed into the ATPI-Mdn1 density as a single rigid body without 
further adjustment (Figure 5-1E). 
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Figure 5-1. Overall architecture of Mdn1 in the presence of ATP and Rbin-
1. (A) Selected class averages of vitrified Mdn1 in the presence of ATP (1 mM)
and Rbin-1 (1 μM), a chemical inhibitor of Mdn1 (hereafter, ATPI-Mdn1). (B) 
Two views of the density map (yellow surface) with a Cα-backbone model for 
the region of Mdn1 N-terminal of the hinge point (ribbon colored as in Figures 
4-1A). This model does not include the H2 insertions of AAA2 and AAA4. The 
ring-linker junction, comprised of N domain, AAA1-L, AAA6-L and linker 
domain, is outlined (black dashed lines). (C) Schematic highlighting the ring-
linker junction (dashed line) is shown. (D) Two views of the overlay of the ring-
linker junctions in AMPPNP-Mdn1 (grey ribbon) and ATPI-Mdn1 (multi-colored 
ribbon, colored as in (C)). (E) Two views of the ATPI-Mdn1 map (yellow 
surface) with the polyalanine-helix model for the entire linker domain (purple 
ribbon representation) generated based on the AMPPNP-Mdn1 map. A density 
not accounted for by the polyalanine-helix model is highlighted (dashed circle). 
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Pairwise comparisons of individual AAA domains reveal that the 
conformations of AAA1 and AAA6 are similar between AMPPNP- and ATPI-
Mdn1 (Figure 5-2A). This may also contribute to the similar orientation of the 
tail relative to the AAA ring. In contrast, substantial differences are found 
across the AAA2-AAA5 domains in these two structures (Figure 5-2A). To 
examine these changes we focused on the structural units called ‘rigid bodies’ 
(‘rigid body i’ is defined as the combination of the AAAi-S and AAA(i+1)-L 
subdomains; as shown in Figure 5-2A), which during conformational changes 
in AAA proteins can move as single structural units (see comparisons in 
Figure 5-2B) (Glynn et al., 2009; Matyskiela et al., 2013). Rigid bodies 1, 4 and 
5 rotate slightly but are essentially on the same plane as the AAA1-L 
subdomain and occupy similar positions in AMPPNP- and ATPI-Mdn1 (Figures 
5-2C and D). In contrast, large displacements (>15 Å) of rigid bodies 2 and 3 
between the two states are observed (Figures 5-2C and D). Together, these 
data suggest that local conformational changes of Mdn1’s AAA ring are linked 
to ATPase activity at a subset of sites.  
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Figure 5-2. Comparisons of AAA domains in AMPPNP-Mdn1 and ATPI-
Mdn1. (A) Alignment of the individual AAA domains (AAA1-AAA5 and AAA6-L) 
in AMPPNP-Mdn1 (orange) and ATPI-Mdn1 (blue). The models were aligned 
using the large subdomains. (B) Alignment of individual rigid bodies and AAA1-
L in AMPPNP-Mdn1 (orange) and ATPI-Mdn1 (blue). The models were aligned 
based on the large subdomains. Note that there is no substantial 
conformational difference within individual rigid bodies between the two states, 
suggesting these rigid bodies move together during conformational changes. 
(C) Schematics of the five rigid bodies (cylinders) and AAA1L (shorter cylinder) 
in AMPPNP-Mdn1 (orange) and ATPI-Mdn1 (blue) and an overlay of them 
aligned using AAA1-L. The displacements of rigid bodies 2 and 3 (black 
arrows) are also indicated in the overlay. (D) The arrangement of individual 
rigid bodies in AMPPNP-Mdn1 (orange ribbon) and ATPI-Mdn1 (blue ribbon) 
when the two models are aligned using their AAA1-L subdomain. The 
displacements of rigid bodies 2 and 3 (black arrows) are indicated. 
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We next examined the densities in the ATPI-Mdn1 map that could not 
be readily assigned using the AMPPNP-Mdn1 model (Figure 5-3A). First, on 
the face of the AAA ring, opposite to the one from which the tail extends, there 
is unassigned density that adjoins AAA4-L (filled red arrowheads in Figures 5-
3A). Further, this density is directly connected to the residues flanking the 
AAA4 H2 insertion (Figures 5-3A, filled red arrowheads) that initially could not 
be modeled. We find that the three-helix bundle modeled for the AAA4 H2 
insertion in the AMPPNP-Mdn1 structure fits into this density (Figure 5-3B). 
The relative orientation of the AAA4-L subdomain and its H2 insertion differs 
only slightly between the AMPPNP- and ATPI-Mdn1 structures (Figure 5-3C), 
suggesting that the AAA4 H2 insertion moves together with the AAA4-L 
subdomain during the conformational changes of Mdn1. 
103 
Figure 5-3. Occlusion of the central hole of the AAA ring and docking of 
the C-terminal MIDAS domain onto the N-terminal AAA ring in ATPI-
Mdn1. (A) Two views of the unassigned density (yellow surface) and the initial 
ATPI-Mdn1 model (colored as in Figure 4-1A). The red spheres indicate the 
residues flanking the H2 insertions of AAA4 (filled red arrowheads) and AAA2 
(empty red arrowheads). (B) Two views of the unassigned densities (yellow 
surface) that extend from the residues flanking the AAA4 H2 insertion (red 
spheres, top panel has the same view as in the left panel of (A)). The model 
for AAA4 H2 insertion in AMPPNP-Mdn1 was fitted into the density. (C) 
Alignment of the models of AAA4-L with its H2 insertion from the structures of 
AMPPNP-Mdn1 (orange ribbon) and ATPI-Mdn1 (blue ribbon). (D) Two views 
of the unassigned densities (yellow surface) that extend from the residues 
flanking the AAA2 H2 insertion (red spheres, views as in (A)). A constriction in 
this density (asterisk) is also highlighted. (E) Potential steric clashes between 
the H2 insertions of AAA2 and AAA4 in ATPI-Mdn1 if the AAA2 H2 insertion 
adopts the same conformation as in AMPPNP-Mdn1. The model for AAA2-L 
with its H2 insertion from AMPPNP-Mdn1 (orange ribbon) was aligned to the 
model for the AAA2-L subdomain. The model for the AAA4 H2 insertion from 
the ATPI-Mdn1 structure is shown in blue. (F) Two views of the AAA ring in the 
model for AMPPNP-Mdn1 (orange ribbon), with AAA2 H2 insertion (green 
ribbon) highlighted. Conserved aromatic residues (black spheres) near the 
beginning of the H2 helix in Mdn1’s AAA domains (also labeled in Figure 1-4). 
(G) Model for the AAA ring (blue ribbon) of ATPI-Mdn1 and density 
representing the AAA2 H2 insertion and the MIDAS domain (yellow surface). 
The conserved Tyr-198 residue is in direct contact with the density assigned 
as the AAA2 H2 insertion. (H) Two views of the homology model for the 
MIDAS domain (magenta ribbon, aa Pro4499-Gln4712) that was fit into the 
density shown in (B) (yellow surface). Only the density above the constriction 
in (D) is shown. The N-terminal end of the model (N’) connects to unassigned 
densities (dashed circles in (D) and (F)). (I) Schematic of ATPI-Mdn1 model 
highlighting the occlusion of AAA ring by AAA2 H2 insertion and the docking of 
MIDAS domain onto the AAA2 and AAA3 domains is shown. 
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An additional density that extends from the same face of the AAA ring 
as the AAA4 H2 insertion was assigned to the AAA2 H2 insertion, as it 
connects to residues flanking the H2 insertion of AAA2 (Figures 5-3A and D, 
open red arrowheads). This density extends into the central hole of the AAA 
ring. The additional unassigned density that passes through the ring is not 
likely to be part of the AAA2 H2 insertion, as it is separated from the density 
representing the H2 insertion by a constriction (Figure 5-3D, asterisk). In 
AMPPNP-Mdn1, the AAA2 H2 insertion forms a four-helix bundle and covers 
only part of the central hole (Figure 4-3A). This four-helix bundle at this 
position in ATPI-Mdn1 would clash with the AAA4 H2 insertion density (Figure 
5-3E). It is possible that the displacement of the AAA4-L domain during the 
ATPase cycle leads to the reorganization of the AAA2 H2 insertion. The 
occlusion of the central hole in the AAA ring is reminiscent of substrate binding 
in AAA unfoldases (Monroe et al., 2017; Puchades et al., 2017; Ripstein et al., 
2017). 
In AAA unfoldases, conserved aromatic residues in an ‘Ar-Φ-Gly’ 
tripeptide (Ar: aromatic residue; Φ: hydrophobic residue, named ‘pore loop’) 
interact with substrates inside the central hole of the AAA ring (Monroe et al., 
2017; Puchades et al., 2017). Interestingly, Mdn1’s AAA3 domain possesses a 
conserved ‘Tyr-Ile/Leu-Gly’ motif. The other AAA domains in Mdn1 lack this 
motif but are enriched in glycine, aromatic and hydrophobic residues at 
corresponding sites near the beginning of the H2 helix (Figure 1-4). All of 
these aromatic residues lie proximal to the central hole in AMPPNP-Mdn1 and 
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only Tyr-198 in AAA1 could be modeled in our ATPI-Mdn1 map (Figures 5-3F 
and G). In ATPI-Mdn1, Tyr-198 in the AAA1 domain is in direct contact with 
the density that we assigned as the H2 insertion of AAA2 inside the central 
hole (Figure 5-3G), suggesting that this residue may contribute to interactions 
with and stabilization of the sequence that occludes the central hole. 
Finally, the unassigned density on the same face as the hook-shaped 
tail positioned above rigid bodies 2 and 3 is sufficiently resolved to reveal well-
defined secondary-structure elements (Figures 5-3A and D). As substantial 
portions of the well-defined structural domains in Mdn1, including the N 
domain, AAA domains and linker domain, are already accounted for the map 
(Figures 5-1E and 5-3A), the D/E-rich and MIDAS domains are the only 
candidate contributors to this unassigned density that encloses a volume 
larger than a typical ~150 aa AAA-L subdomain in the same map. 
Furthermore, the flexibility of D/E-rich is likely independent of the nucleotide 
states of the AAA domains as the flexibility results from the highly biased 
amino acid composition of the domain (>35% Asp/Glu), leaving the MIDAS 
domain (aa 4381-4717) as the potential identity of this unassigned density. 
Interestingly, the unassigned density possesses features that were similar to 
those observed in MIDAS domains of integrin receptors (Song et al., 2005; 
Xiong et al., 2002). Indeed, a homology model for the MIDAS domain, which 
consists of a central β-sheet surrounded by seven α-helices, could be 
unambiguously fit into this density (Figure 5-3H) (Song et al., 2005). Together, 
these data indicate that, when the central hole is blocked, the C-terminal 
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MIDAS domain, located ~2000 aa from the N-terminal AAA domains, docks 
onto the AAA ring (Figure 5-3I). 
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5.3 ATPI-Mdn1 can be docked into cryo-EM maps of the Rix1 particle 
Mdn1 is required for the removal of assembly factors, including the 
removal of Rsa4 from the Rix1 particle, a precursor of the 60S subunit 
(Kressler et al., 2012; Matsuo et al., 2014; Ulbrich et al., 2009). Recent studies 
have characterized the structures of the S. cerevisiae Rix1 and Nog2 particles 
(Barrio-Garcia et al., 2016; Wu et al., 2016). These structures indicate that 
Rea1, the S. cerevisiae Mdn1 ortholog, binds the core of the pre-60S particle 
through a limited portion of the AAA ring’s outer edge. The tail of Rea1, for 
which only weak density is observed, extends away from the Rix1 particle 
(Barrio-Garcia et al., 2016). We find that our ATPI-Mdn1 model fits well into 
the Rea1 density (Figures 5-4A to C). Remarkably, the ATPI-Mdn1 MIDAS 
domain occupies density in the Rix1-particle map that was previously 
unassigned (Barrio-Garcia et al., 2016; Wu et al., 2016). Importantly, this 
density that we now assign as the MIDAS domain, is adjacent to the density 
corresponding to the ribosome assembly factor Rsa4 in the Rix1-particle 
model (Barrio-Garcia et al., 2016; Wu et al., 2016). In this arrangement, 
residues that have been shown to be critical for Mdn1-Rsa4 interaction 
localize to the interface between the MIDAS and Rsa4 domains (Figure 5-4D) 
(Ulbrich et al., 2009). When contoured at a lower threshold level, the Rix1-
particle map also reveals densities that correspond to the linker domain and 
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the AAA4 H2 insertion in our ATPI-Mdn1 structure (Figure 5-4C). These 
analyses reveal that our ATPI-Mdn1 structure mirrors the conformation of 
Mdn1 in the Rix1 particle, in which the MIDAS domain can directly interact with 
both the AAA domains and Rsa4. This model suggests that inhibition of Mdn1 
by Rbin-1 would not preclude the assembly of the Rix1 particle but may block 
the release of Rsa4, which is consistent with our findings that acute inhibition 
of Mdn1 by Rbins can result in an enrichment of Rsa4 on Rix1 particles 
purified from fission yeast cells (Kawashima et al., 2016). 
Interestingly, our model also reveals that ATPI-Mdn1 makes direct 
contact with the core of the Rix1 particle through its rigid bodies 2 and 3 
(Figures 5-4A and B), which we find undergo substantial displacements 
relative to their positions in AMPPNP-Mdn1 to create a binding site for the 
MIDAS domain. On the other hand, the AMPPNP-Mdn1 model could not be 
docked into the Rix1-particle map. In particular, there is a clear mismatch 
between AMPPNP-Mdn1’s AAA ring and the density proximal to the core of 
the Rix1 particle (Figure 5-4E), suggesting that Mdn1 associates with the Rix1 
particle in a nucleotide state-specific manner. 
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Figure 5-4. Mdn1 interacts with other components of the Rix1 particles in 
a nucleotide state-specific manner. (A and B) Two views of the ATPI-Mdn1 
model and the Rsa4 crystal structure (cyan, C. thermophilum, PDB: 4WJS) 
placed into the density map of the Rix1 particle (EMDB: 3199). For clarity, only 
the AAA ring (blue) and MIDAS domain (magenta) of ATPI-Mdn1 are shown. 
Details of the model fitting are described in the Methods section. Rigid bodies 
2 and 3 of Mdn1’s AAA ring (dashed triangles) are indicated in (B). (C) A 
zoomed-out view of (A) and the map of ATPI-Mdn1 (yellow surface). A lower 
threshold compared to (A) was used to contour the map of the Rix1 particle. 
The densities in the Rix1 particle that likely correspond to the linker domain 
and the AAA4 H2 insertion are circled.  (D) The model for the MIDAS domain 
(magenta) and the N-terminal ubiquitin-like domain of Rsa4 (cyan) shown in 
the same orientation as (B). The Cα carbons of residues (spheres) implicated 
in the interaction between the MIDAS domain (Asp-4511, Ser-4513, Ser-4515, 
Thr-4582 and Asp-4619 in S. pombe Mdn1, also labeled in Supplementary 
Data Item 1) and Rsa4 (Glu-117 in C. thermophilum Rsa4, equivalent to Glu-
114 in S. cerevisiae Rsa4) are highlighted. (E) Docking of the AMPPNP- and 
ATPI-Mdn1 models generated in this work into the density map of the Rix1 
particle (EMDB: 3199). Rigid bodies 2 and 3 of Mdn1’s AAA ring (black oval) 
are indicated in AMPPNP-Mdn1. 
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We then analyzed the conservation of the primary sequence among 
Mdn1 orthologs from yeast to human and mapped the conservation scores of 
individual residues onto the surface models of both AMPPNP- and ATPI-Mdn1 
using ConSurf (Figures 5-5A to C) (Ashkenazy et al., 2016). Interestingly, 
AMPPNP-Mdn1 has a highly conserved surface above rigid bodies 2 and 3 in 
the AAA ring (Figure 5-5A), which is covered by the MIDAS domain in ATPI-
Mdn1 (yellow dashed circle in Figure 5-5B). The surface of the MIDAS domain 
is overall conserved, including the region facing the AAA ring (Figure 5-5C) 
and the Rsa4-binding site (Figure 5-5B). The conservation level of the outer 
circumference of the AAA ring is variable, with higher conservation scores for 
residues near rigid bodies 2 and 3 that are in direct contact with the core of the 
Rix1 particle (Figures 5-5A and B).  
To test the functional significance of the residues at the interface 
between the MIDAS domain and the AAA ring we used fission yeast genetics. 
In particular, we used a ‘ts-mdn1 complementation assay’, in which different 
Mdn1 mutants are overexpressed in a temperature-sensitive mdn1 mutant 
strain and the growth of cells at the restrictive temperature is measured 
(Figure 5-5D-F) (Kawashima et al., 2016). We focused on a conserved loop in 
the MIDAS domain that is enriched in aromatic residues and is buried when 
the MIDAS domain docks onto the AAA ring. We generated a mutant construct 
(aa 4685-4690: FAFDYY to AAADAA, hereafter, named 4A-Mdn1) with the 
goal to disrupt this interaction (Figure 5-5D). As controls, we also tested 
mutant constructs in which residues at the edge of the same docking interface 
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were mutated to reverse their charges (D1123R-Mdn1 and R4694D-Mdn1). 
The cell-based assay indicated that 4A-Mdn1 cannot complement Mdn1 
function in cells at the restrictive temperature, while the D1123R and R4694D 
mutants can (Figure 5-5F). We also generated recombinant wild-type MIDAS 
(aa 4381-4717) and mutant MIDAS (aa 4381-4717, FAFDYY to AAADAA, 
named 4A-MIDAS hereafter) domain constructs and found that both proteins 
eluted from a size-exclusion column at similar volumes (9.9 and 10.0 mL) 
(Figure 5-5G), suggesting that mutations in the aromatic loop in the MIDAS 
domain do not affect its overall folding. Together, these data are consistent 
with our model that the intramolecular docking of MIDAS on the AAA ring is 
required for Mdn1 function. 
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Figure 5-5. Analysis of the intramolecular docking of MIDAS domain on 
the AAA ring using a cell-based assay. (A-C) Residue conservation mapped 
onto the surfaces of (A) AMPPNP-Mdn1, (B) ATPI-Mdn1, and (C) ATPI-Mdn1 
without the MIDAS domain and the surface of the MIDAS domain that interacts 
with the AAA ring. The region where the MIDAS domain docks onto the AAA 
ring are highlighted (yellow dashed ovals) in (B) and (C). (D) Two orthogonal 
views of the ATPI-Mdn1 model showing the Cα atoms of the aromatic residues 
of the FAFDYY sequence (aa 4685-4690, green spheres) and the Cα atoms of 
residues D1123 and R4694 (black spheres). (E) Schematic of the yeast 
complementation assay using a ts-mdn1 strain. (F) The OD590 values of 
exponentially growing cell cultures of ts-mdn1 strains overexpressing wild-type 
(WT) Mdn1 or the indicated mutants (4A-Mdn1: aa 4685-4690, ‘FAFDYY’ to 
‘AAADAA’, D1123R-Mdn1 and R4694D-Mdn1) of full-length Mdn1 (n=3, mean 
± SD). The data for the vector control are also shown. (G) Overlay of the size-
exclusion chromatography profiles for the wild-type MIDAS domain (aa 4381-
4717) and mutant 4A-MIDAS domain (aa 4381-4717, loop 4685-4690 
mutation: FAFDYY to AAADAA). The elution volumes of both proteins are 
indicated for comparison. The SDS-PAGE analysis (Coomassie blue stain) of 
WT-MIDAS and 4A-MIDAS are shown in the inset. The major bands match the 




Together, our single-particle cryo-EM studies reveal two distinct 
conformations of Mdn1. These structural models, along with biochemical and 
cell-based analyses, suggest how conformational changes in Mdn1 contribute 
to ribosome biogenesis. 
5.4.1 Insights into the Conformational Dynamics of Mdn1’s C-terminal 
Tail 
Our studies shed light on the conformational dynamics of Mdn1’s C-
terminal tail, comprised of the linker, D/E-rich and MIDAS domains. The linker 
domain adopts similar conformations in all three of our Mdn1 density maps 
(Figures 4-1C, 4-5G and 5-1B) and also has a similar orientation relative to the 
AAA ring in Rea1 in the published map (~10 Å local resolution) of the budding 
yeast Rix1 particle (Figure 5-4C). In our datasets, different 3D classes reveal a 
hinge point in the linker domain that results in small changes in orientation 
(<10°, Appendix Figures 4-1B and 5-1B). We did not see any 3D classes in 
which the linker bends substantially. In addition, the D/E-rich domain was not 
resolved in any of the aforementioned structures, suggesting its nature of 
flexibility. We propose that Mdn1’s linker domain serves as a structural 
extension from the AAA ring, similar to a fishing pole, to which the MIDAS 
domain is tethered through the D/E-rich motif. The flexibility of the D/E-rich 
domain could allow intramolecular docking of the MIDAS domain on the AAA 
ring in Mdn1 (see the model in Figure 5-6A), allowing their direct coupling.  
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Figure 5-6. Model for the function of Mdn1 during ribosome biogenesis. 
(A) Schematics of two distinct Mdn1 conformations observed in this study. The 
linker, D/E-rich and MIDAS domains are indicated. Individual AAA domains are 
colored as in Figure 4-1A. The magenta arrows indicate the undefined location 
of the MIDAS domain in AMPPNP-Mdn1. Additional ATP binding and 
hydrolysis by Mdn1 can lead to additional conformational changes (dashed 
arrow). (B) Comparison of lengths of individual domains in Mdn1 orthologs 
from H. sapiens, S. pombe and E. cuniculi. The relative lengths of individual 
domains (normalized to the length of the corresponding domains in S. pombe 
Mdn1) are listed for H. sapiens and E. cuniculi Mdn1. (C) Mdn1 adopts a 
conformation similar to ATPI-Mdn1 in the Rix1 particle. Additional ATP binding 
and hydrolysis can lead to local conformational changes in the AAA ring and 
displace the MIDAS domain to release Rsa4 from the Rix1 particle. 
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Interestingly, alignment of Mdn1 orthologs reveals the evolutionary 
constraints on individual domains in Mdn1. As mentioned previously, the linker 
and D/E-rich domains are conserved moderately compared to the AAA and 
MIDAS domains (sequence identities: ~20% vs ~50%, see Table 4-1). In 
addition, H. sapiens Mdn1 has ~20-30% longer linker and D/E-rich domains 
compared to S. pombe Mdn1, while the lengths of the AAA and MIDAS 
domains are very similar (<2% difference) (Figure 5-6B). On the other hand, a 
much smaller Mdn1 ortholog is found in the eukaryotic parasite E. cuniculi 
(2832 aa), in which the primary sequence suggests that the lengths of the 
linker and D/E-rich domains are reduced by ~60%, compared to S. pombe 
Mdn1, while the lengths of the AAA and MIDAS domains are reduced by only 
~20% (Figure 5-6B) (Garbarino and Gibbons, 2002). These comparisons 
suggest that the linker and D/E-rich domains in Mdn1 are much more prone to 
genetic drift and tolerant to reductions in length, while there are more stringent 
constraints on the residues in the AAA and MIDAS domains, which are 
involved in specific intramolecular or intermolecular interactions critical for 
Mdn1 function (Figure 5-5). Our analysis also reveals that the length of the 
linker domain correlates with that of the D/E-rich domain, indicating that a 
longer linker domain may be compensated by a longer D/E-rich domain 
serving as a tether, and suggests that our proposed intramolecular docking 
mechanism for Mdn1 is likely conserved across eukaryotes.  
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5.4.2 Mdn1 Remodels Precursors of the 60S Ribosome 
Our structures also suggest a simple model for how nucleotide-
dependent conformational changes of Mdn1 contribute to ribosome 
biogenesis. In solution, Mdn1 could bind ATP and adopt conformations similar 
to that of AMPPNP-Mdn1. In this state, the MIDAS domain would sample 
different positions but not stably dock onto the AAA ring. ATP hydrolysis within 
the AAA2-AAA5 domains would drive displacements of rigid bodies 2 and 3 
(Figure 5-6A). These movements would displace AAA4-L and its H2 insertion, 
resulting in a steric clash with Mdn1’s AAA2 H2 insertion, causing its 
reorganization such that it inserts into the central hole of the AAA ring. 
Together, these changes would create a site for the C-terminal MIDAS domain 
to dock onto the AAA ring (Figure 5-6A). This conformation is capable of 
stabilizing an interaction network formed by the core of the Rix1 particle, Rsa4 
and Mdn1’s MIDAS domain and rigid bodies 2 and 3 (Figure 5-6C). It is also 
possible that Rsa4 and the pre-60S particle core can stimulate Mdn1’s activity 
and catalyze these conformational transitions. As the final step, additional ATP 
binding, hydrolysis or nucleotide release could reorganize these dynamic 
regions in Mdn1 and promote the breakdown of the interaction network in the 
Rix1 particle to release Rsa4 and Mdn1 (Figure 5-6C). 
Our proposed model is consistent with previous biochemical assays 
showing that addition of ATP, but not AMPPNP, to affinity-purified Rix1 particle 
triggers the release of Mdn1 and Rsa4. It has also been shown that a Walker 
A lysine-to-alanine substitution at the AAA3 ATPase site does not affect the 
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association of Mdn1 with the Rix1 particle but blocks the release of 
Mdn1/Rsa4 upon ATP addition (Barrio-Garcia et al., 2016). Interestingly, our 
data show that Mdn1 bound to the Rix1 particle adopts a conformation 
corresponding to ATPI-Mdn1, which has a wider opening in AAA3 compared 
to what is observed in AMPPNP-Mdn1 (Figure 5-2A), consistent with AAA3 
being in the apo state. In addition, our data suggest that rigid bodies 2 and 3 in 
Mdn1, which flank the AAA3 ATPase site, would likely be displaced in the 
ATPase cycle. We speculate that the lack of ATP binding or hydrolysis in the 
AAA3 ATPase site of the AAA3 Walker A mutant restricts conformational 
changes of rigid bodies 2 and 3 needed for the release of Rsa4. In addition, 
we can use our structural model for Mdn1 to map the single-point mutations 
that alter the potency of Rbin-1 in fission yeast cells (Figure 5-7) (Kawashima 
et al., 2016). Interestingly, seven different resistance-conferring mutations and 
one sensitivity-conferring mutation all lie in the AAA3-S and AAA4-L 
subdomains, suggesting that Rbin-1 directly or allosterically affects the 
conformational transitions of rigid body 3 in Mdn1.  
Previous studies have revealed that the H2 insertion of AAA2 in Mdn1 
interacts with the C-terminal sequence of Rix1 in a Rix1-Ipi1-Ipi3 complex and 
this interaction is required for the recruitment of Mdn1 to the Rix1 particle 
(Barrio-Garcia et al., 2016). Currently, it is not known whether this interaction 
exists in the Rix1 particle or is only established before the assembly of the 
Rix1 particle. Our structures reveal the dynamic nature of this H2 insertion in 
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Mdn1 and suggest that its displacement could be coupled to its binding state 
with the C-terminal sequence of Rix1. 
Figure 5-7. Resistance- and sensitivity-conferring mutations to Rbin 
activities in S. pombe cells mapped to ATPI-Mdn1 model. The α carbons 
of residues that can suppress or sensitize the activity of Rbin-1 in cells are 
highlighted in the ATPI-Mdn1 model (green and red spheres, respectively). 
Rigid bodies 2 and 3 are outlined (dashed triangles). 
In addition to remodeling the Rix1 particle, previous studies suggest 
that in S. cerevisiae, Mdn1 also releases Ytm1 from nucleolar pre-60S 
intermediates. This remodeling step requires the interaction between Mdn1’s 
MIDAS domain and the N-terminal domain of Ytm1 (Bassler et al., 2010; Kater 
et al., 2017). A recent cryo-EM structure of the Nsa1 particle reveals the 
position of Ytm1 on the pre-ribosomes. Alignment of the Nsa1 particle to the 
Rix1 particle, using common motifs, indicates that Ytm1 binds to the core of 
the pre-60S particle at essentially the opposite side from where Rsa4 binds 
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(separation ~25 nm) (Barrio-Garcia et al., 2016; Kater et al., 2017). However, 
Rea1 and the N-terminal domain of Ytm1 are not resolved in the Nsa1 particle. 
Therefore, at this stage, we do not know the precise interactions needed to 
remodel the Nsa1 particle or other nucleolar pre-ribosomes. It is likely that the 
MIDAS domain would dock on the AAA ring and then interact with the N-
terminal domain of Ytm1, similar to the AAA ring-MIDAS-Rsa4 configuration in 
the Rix1 particle. This would suggest that Mdn1’s AAA ring has to be recruited 
proximal to Ytm1 in the nucleolar pre-60S particle. Further studies are needed 
to test this hypothesis. 
5.4.3 Comparisons of Mdn1 to dynein and other AAA unfoldases 
While the overall conformational dynamics of Mdn1 can be considered 
to be unlike what has been described for dynein, some common principles are 
apparent. Dynein, like Mdn1, has a pseudo-hexameric AAA ring and >10 nm 
protrusions extending from the ring, all within a single polypeptide (Schmidt 
and Carter, 2016). The ATPase activity of AAA1 in dynein is thought to drive 
local conformational changes of the AAA ring, and to create two alternative 
intramolecular binding sites for its cargo-binding domain (Schmidt and Carter, 
2016). Our structural data reveal that similar to dynein, Mdn1 also couples 
nucleotide hydrolysis at a subset of ATPase sites to create an intramolecular 
docking site for its MIDAS domain. 
Mdn1 also shares similarities with AAA unfoldases, such as Yme1 and 
Vps4. These unfoldases translocate different protein substrates through the 
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central hole of the AAA ring to unfold them for further processing (e.g., 
proteolysis) (Monroe et al., 2017; Puchades et al., 2017). In the case of Mdn1, 
the central hole in its AAA ring is also occupied by a polypeptide whose 
insertion appears to be nucleotide state-dependent. However, unique to Mdn1, 
the inserted motif does not derive from a different substrate protein but is a 
segment of the same polypeptide. We posit that the occlusion of the central 
hole by the H2 insertion of AAA2 serves an auto-regulatory function. Together, 
our data reveal how conformational dynamics required for the functions of 
different AAA proteins can be combined in Mdn1, an unusually large protein, 
to remodel ribosome precursors.  
5.5 Methods 
Biochemical preparation of full-length S. pombe Mdn1. 
The full-length S. pombe Mdn1 was prepared as described in Method 
2.5. 
Recombinant wild-type MIDAS domain (aa 4381-4717) or 4A-MIDAS 
domain (aa 4685-4690: FAFDYY to AAADAA) were cloned into pET28 vector 
and overexpressed in E. coli. The cells were lysed by French press in lysis 
buffer (20 mL lysis buffer per 1 L culture; 50 mM Tris [pH 7.5], 150 mM NaCl, 
20 mM imidazole, 1 mM MgCl2, 5 mM 2-mercaptoethanol, 3 U/mL benzonase, 
1X Roche complete protease inhibitor without EDTA and 10% glycerol). All of 
the following steps were carried out on ice or at 4 °C. The lysate was 
centrifuged at 55,000 rpm for 30 min. The supernatant was incubated with Ni-
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NTA beads (QIAGEN) for 40 min. The beads were washed using washing 
buffer (50 mM Tris [pH 7.5], 150 mM NaCl, 20 mM imidazole, 1 mM MgCl2, 5 
mM 2-mercaptoethanol and 10% glycerol) and then eluted with 300 mM 
imidazole in the washing buffer. The eluted protein was concentrated using 
Amicon Ultra-4 Centrifugal Filter Units (Millipore UFC805008) and loaded on a 
Superdex 75 16/60 column (GE Healthcare Life Sciences) in size-exclusion 
buffer (20 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM MgCl2 and 2 mM 2-
mercaptoethanol). The eluted fractions were analyzed by SDS-PAGE and 
fractions corresponding to expected molecular weight (~42 kDa) were 
concentrated and loaded on a Superdex 75 10/300 column (GE Healthcare 
Life Sciences) using the same size-exclusion buffer. 
Cryo-EM sample preparation and data collection.  
To prepare cryo-EM grids of full-length Mdn1 with ATP and Rbin-1, the 
purified protein was concentrated to ~0.15 mg/mL using centrifugal filters (MW 
cutoff: 50 kDa; Millipore) and mixed with 10x (ATP+Rbin-1) stock solution 
(final concentration: 1 mM ATP, 1 μM Rbin-1, 2 mM Na2SO4 and 0.2% 
DMSO). Samples were applied to Quantifoil R1.2/1.3 400 mesh Cu holey 
carbon grids (Quantifoil) covered with a homemade thin carbon film, and then 
blotted and frozen in liquid ethane with a Cryoplunge 3 system (Gatan). Cryo-
EM data were collected on a 200-kV Talos Arctica electron microscope 
(Thermo Fisher Scientific) equipped with a K2 Summit detector (Gatan) at a 
nominal magnification of 28,000x in super-resolution counting mode. After 
binning over 2 x 2 pixels, the calibrated pixel size was 1.5 Å on the specimen 
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level. Exposures of 15 s were dose-fractionated into 50 frames with a dose 
rate of 10 electrons pixel-1 s-1, resulting in a total dose of 66.7 electrons Å-2. 
Defocus values ranging from -2.0 to -4.0 μm were used. 
Cryo-EM data processing.  
All movie frames were corrected with a gain reference collected in the 
same EM session, and specimen movement was corrected using MotionCor2 
with dose weighting (Zheng et al., 2017). Images showing substantial ice 
contamination, abnormal background, thick ice or low contrast were discarded. 
The contrast transfer function (CTF) was estimated using CTFFIND4 (Rohou 
and Grigorieff, 2015). Approximately 10,000 particles were manually picked, 
subjected to 2D classification, and the resulting averages were used as 
templates for automatic particle picking using either RELION 1.4 for the pilot 
dataset of ATPI-Mdn1 only (Scheres, 2012) or Gautomatch for all other 
datasets (http://www.mrc-lmb.cam.ac.uk/kzhang/Gautomatch/). In particular, 
six representative 2D averages were rotated every 30° over 360° to generate 
seventy-two 2D views and then used as templates in Gautomatch. Particles 
selected for all micrographs were visually inspected, and poorly selected 
particles were manually adjusted or discarded. The final dataset for ATPI-
Mdn1 contained 247,841 particles, respectively. 
For ATPI-Mdn1 dataset, an initial pilot dataset containing 80,152 
particles (box size: 256 x 256 pixels) was subjected to 2D classification using 
RELION 1.4 (Appendix Figure 5-1B). Classes that produced poor averages 
were discarded. Averages showing representative views were used to 
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generate an initial density map with the VIPER command implemented in 
SPARX (Hohn et al., 2007). The particles after 2D clean-up were then 
subjected to 3D classification into eight classes using the VIPER map as an 
initial reference. Subsequent refinement and post-processing of the best class 
yielded a map at 17.5-Å resolution (FSC = 0.143). A mask big enough to cover 
all 3D classes was then generated and used to process the complete dataset. 
For the complete dataset, all particles (247,841 particles) were subjected to 
2D classification in RELION 2.0 and poor averages were discarded (See Table 
5-1 for statistics for processing the complete dataset) (Kimanius et al., 2016). 
The remaining 210,668 particles were refined to the final map from the pilot 
dataset filtered to 25-Å resolution with the mask. A subsequent 3D 
classification into eight classes without alignment yielded one class (containing 
54,557 particles) that showed better-resolved structural features. Refinement 
of this class yielded the final density map at a resolution of 7.7 Å (FSC = 
0.143, Appendix Figure 5-1D). Local-resolution map of ATPI-Mdn1 was 
calculated by ResMap in RELION 2.0 (Appendix Figure 5-1E). These local 
resolution maps represent relative differences in resolution across the maps 
but that the absolute values may not be exact. 
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 Microscope Talos Arctica 
 Detector K2 Summit 
 Pixel size (Å) 1.5 
 Voltage (kV) 200 
 Total electron exposure (e–Å-2) 66.7 
 Defocus range (μm) -2.0 to -4.0 
Reconstruction (RELION) 
 Particle number 54,557 
 Box size (pixels) 256 
 Resolution (Å) (FSC = 0.143) 7.7 
 B-factor (Å2) -476 
Model building and refinement. 
To interpret the map for ATPI-Mdn1, the AMPPNP-Mdn1 model was 
divided into the N domain, the individual AAA subdomains and the linker 
domain before the hinge. Using Chimera, the models for these domains were 
individually fit as rigid bodies into the ATPI-Mdn1 density map. The entire 
AAA6-L subdomain, including its H2 insertion, and the H2 insertion of AAA4 
from AMPPNP-Mdn1 fit well into the ATPI-Mdn1 map. The model for the H2 
insertions of AAA2 in AMPPNP-Mdn1 could not be readily fit and was 
therefore not modeled in the ATPI-Mdn1 map. The models for the different 
domains were then combined, and rigid-body refinement was performed using 
the phenix.real_space_refine command in PHENIX with secondary structure 
restraints.  
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Models for the MIDAS domain were built using RosettaCM (Song et al., 
2013). Homology modeling was carried out using seven templates (PDB: 
1AUQ, 1IJB, 1MF7, 1SHU, 4HQO, 5HGJ, and 5HJ2) identified by hhsearch 
(Soding, 2005). For each template, a “partial thread” was generated, in which 
residue identities were changed to the target sequence but the backbone was 
kept fixed. Residues not present in each template were not modeled. To 
determine the overall orientation of these models within the target density in 
the ATPI-Mdn1 map, a rotational search was carried out in Rosetta around this 
density region, using a modified version of a previously developed fragment-
docking method (Wang et al., 2015). For each of the seven templates, the 
rotational search identified a single orientation with much better density 
agreement than any other. Rosetta-based homology modeling was then 
carried out, combining pieces from the seven homologous structures and 
refining the models with the Rosetta all-atom energy function that was 
augmented with a term assessing the agreement of the model to the density. 
In total, 1500 models were generated, and the models with the lowest overall 
energy were selected. The five lowest-energy models were quite well 
converged (inter-structure root-mean-square deviations < 1.5 Å), giving fairly 
high confidence in the final models. 
Fitting of the ATPI-Mdn1 model into the Rix1-particle map.  
As shown in Figures 5-5A to C, the model for ATPI-Mdn1 and the 
crystal structure of Rsa4 (cyan, C. thermophilum, PDB: 4WJS) were docked 
into the published density map of the Rix1 particle (gray surface, EMDB: 
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3199). The docking of Rsa4 was guided by the reported model for the Rix1 
particle (PDB: 5FL8) that was based on the same map (EMDB: 3199). A slight 
adjustment was necessary to prevent inappropriate fitting of the Rsa4 
structure into a previously unknown density, which we assigned, based on our 
model in the current work, as the MIDAS domain of Mdn1. 
Calculation of surface conservation with the ConSurf server.  
The Clustal Omega server was used to align the Mdn1 orthologs from 
sixteen species (Schizosaccharomyces pombe Mdn1, Uniprot: O94248; 
Saccharomyces cerevisiae Mdn1, Uniprot: Q12019; Candida albicans Mdn1, 
Uniprot: A0A1D8PL61; Komagataella phaffii Mdn1, Uniprot: F2QMK3; 
Arabidopsis thaliana Mdn1, Uniprot: A0A1P8AUY4; Dictyostelium discoideum 
Mdn1, Uniprot: Q869L3; Caenorhabditis elegans Mdn1, NCBI: 
NP_001263748.1; Drosophila melanogaster Mdn1, NCBI: NP_001097279.2;  
Danio rerio Mdn1, NCBI: NP_003200751.2; Xenopus tropicalis Mdn1, NCBI: 
NP_002940362.2; Anolis carolinensis Mdn1, Uniprot: G1KPU9; Equus 
caballus Mdn1, Uniprot: F6XJW2; Bos taurus Mdn1, Uniprot: E1BC24; Canis 
lupus Mdn1, Uniprot: J9NZY7; Mus musculus Mdn1, Uniprot: A2ANY6; Homo 
sapiens Mdn1, Uniprot: Q9NU22). The alignment was then analyzed with the 
ConSurf server to determine the conservation values for the individual 
residues (Ashkenazy et al., 2016). The output PDB file, which contains the 
conservation scores as B-factor values, was then displayed in PYMOL.  
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CHAPTER 6 
CONCLUSION AND FUTURE DIRECTIONS 
6.1 Conclusion 
Previous work done by my colleagues in the Kapoor laboratory 
discovered Rbin-1 as the first chemical inhibitor of eukaryotic ribosome 
biogenesis in S. pombe. Chemical genetics studies of S. pombe revealed that 
single-point mutations on mdn1, a gene that encodes the largest AAA protein 
(4717 aa) in the yeast genome, could increase or decrease the sensitivities of 
the cells to Rbin-1.  
Here, I established the overexpression and purification strategies to 
obtain recombinant full-length Mdn1 at high purity. Biochemical 
characterization of recombinant wild-type Mdn1 and its mutant revealed that 
they are both active ATPases in vitro. In addition, Rbin-1 can inhibit the 
ATPase activity of the wild-type Mdn1 but not the mutant protein that carries 
the resistance-conferring single-point mutation, indicating Mdn1 is the 
physiological target of Rbin-1 in cells. 
 In addition, I performed structure-activity-relationship analysis of Rbin-1 
by synthesizing and testing ~20 analogs in cells. Rbin-2 was discovered to be 
a 10-fold more potent compound compared to Rbin-1 in the cell-based assay.  
I then solved three Cryo-EM structures of S. pombe Mdn1 at two 
different nucleotide states. These structures provided the first pseudo-atomic 
models of Mdn1 and revealed that the N-terminal AAA domains and the C-
terminal substrate-interacting motif, the MIDAS domain, are coupled by 
directly interacting with each other at specific nucleotide state. These models 
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also suggest a mechanism of how Mdn1 applies force to its client protein Rsa4 
in pre-60S particles.  
Together, my chemical biology, biochemical and structural studies of 
Mdn1 provided new tools to investigate the function of Mdn1 and unveiled an 
unexpected molecular mechanism for how this unusually large AAA protein 
contributes to ribosome biogenesis in eukaryotes.  
6.2 Future directions 
In the following section, I propose to (i) analyze the intermediates of 
ribosome biogenesis trapped by Rbin-1 in cells to study other steps of 
ribosome biogenesis that require Mdn1 function, (ii) develop chemical 
inhibitors of human Mdn1 to dissect of role of ribosome biogenesis in cellular 
transformation processes and (iii) perform further structural and biophysical 
analysis of Mdn1 to understand its mechanochemical cycle. 
6.2.1 Using Rbins as chemical probes to trap specific ribosome 
intermediates in cells. 
Ribosome biogenesis is a multistep process that involves more than 
200 assembly factors. Each assembly factor binds and unbinds to the 
precursors of ribosomes under tight spatial and temporal regulations, leading 
to a large number of intermediates of ribosomes with distinct protein 
compositions. Specific ribosome intermediates can be separated by 
performing pull-down purification targeting certain assembly factors with 
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affinity tags. However, this method may bias the purification of non-transient 
intermediates. Currently, it is not known how many ribosome intermediates 
exist throughout the whole biogenesis process. In particular, although the 
function of Mdn1 has been implicated in other steps of ribosome biogenesis in 
addition to remodeling of Rix1 particles, the exact intermediates with Mdn1 
bound have not been isolated and characterized so far.  
Interestingly, the addition of Rbin-1 in S. pombe cells appears to 
synchronize the precursors of 60S ribosomal subunits at three specific steps 
(see the three-step decreases of Rpl2501-GFP signal in the nucleolus after 
wash out of Rbin-1 in S. pombe cells, Figure 2-2F). Therefore, I propose to 
use Rbin-1 as a perturbation tool to study these specific ribosome 
intermediates, whose further processing most likely require the function of 
Mdn1. Using the chemical inhibitors, the endogenous populations of ribosomal 
intermediates can be enriched. Biochemical fractionation of the nucleus of 
Rbin-1-treated cells can be performed and sucrose gradient can be used to 
separate the trapped ribosome intermediates. Mass spectrometry analysis of 
these fractions will reveal the protein composition. Careful selection of the 
target proteins for affinity tags can then lead to strategies to separate these 
distinct intermediates. Further biochemical and structural characterization 
using single-particle cryo-EM will reveal the architectures of these ribosomal 
subunits that are relevant to Mdn1 function. These studies can reveal how 
Mdn1 contribute to other remodeling steps of ribosome biogenesis. 
6.2.2 Development of chemical inhibitor targeting human Mdn1. 
An enlarged nucleolus has been used as a prognostic marker for tumor 
development for more than 200 years (Ruggero, 2012). The nucleolus is also 
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where transcription of ribosomal DNA, i.e. the first step of ribosome 
biogenesis, occurs. Recent studies suggest that deregulations of oncoproteins 
and tumor suppressors that occur frequently in a variety of human cancers 
could lead to not only the loss of control in the cell cycle progression, but also 
enhanced ribosome biogenesis (Montanaro et al., 2008). For instance, c-Myc 
and Rb have been shown to regulate the activities of both RNA polymerase I 
and III that are both responsible for the transcription of rDNA (Cavanaugh et 
al., 1995; Gjidoda and Henry, 2013; Gomez-Roman et al., 2006; Hirsch et al., 
2004). However, whether the cellular transformation process requires extra 
ribosomes to meet the high demands for protein synthesis or this upregulation 
of ribosome biogenesis is a bystander effect caused by deregulations of 
important cancer regulators remains an open question. Currently, it has been 
difficult to dissect the role of ribosome biogenesis in the cellular transformation 
process, partially due to the lack of tools to selectively suppress the assembly 
of ribosomes, which is only one of the pathways affected by proteins like c-
Myc or Rb. In addition, recent studies revealed that >20 known 
chemotherapeutic drugs affect ribosome biogenesis at different stages 
according to the analysis rRNA processing (Burger et al., 2010), raising the 
question on how much of the therapeutic effect of these drugs is resulted from 
the suppression of ribosome biogenesis and whether targeting ribosome 
biogenesis in cancer cells would be a viable therapeutic approach (Pelletier et 
al., 2018). Therefore, I propose to generate and purify human Mdn1 and 
screen for selective cell-permeable inhibitors based on in vitro ATPase assays 
and the available library of Rbin analogs (~100 compounds). These 
experiments may provide new tools to dissect the role of ribosome biogenesis 
in the pathogenesis of cancer and it is also interesting to use the inhibitors to 
134 
study the biogenesis pathway in human. These studies may also provide new 
insights into the evolution of ribosome biogenesis in different eukaryotes. 
6.2.3 Structural and biophysical studies of Mdn1. 
The structures of Mdn1 at two different nucleotide states reported in this 
dissertation provided two snapshots of Mdn1 during its ATPase cycle. These 
data revealed the domain organizations of Mdn1 and which domains have to 
undergo substantial conformational changes between these two states. 
However, other conformational intermediates and the contributions of 
individual ATPase sites to the conformational changes are not clear. 
Therefore, I propose to perform single-particle cryo-EM studies of E1637Q-
Mdn1 that cannot hydrolyze ATP in AAA5 ATPase site. Even though there is 
no nucleotide density observed in the AAA5 ATPase site in AMPPNP-Mdn1 
map, the E1637Q-Mdn1 hydrolyzes ATP at a significantly slower rate 
compared to the wild-type Mdn1 (~15%), suggesting ATP hydrolysis in AAA5, 
and ATP binding as a prerequisite, are both important for specific steps of the 
ATPase cycle. Therefore, the structures of this mutant Mdn1 will likely reveal 
conformations of Mdn1 with ATP bound in AAA5 ATPase site. These studies 
may provide insights into the role of ATP hydrolysis in AAA5 ATPase site in 
the mechanochemical cycle of Mdn1.  
In addition to the structural analysis, I propose to perform fluorescence 
resonance energy transfer (FRET)-based assays to examine the kinetics of 
conformational transitions of Mdn1. In particular, I am interested in the 
dynamics of the intramolecular docking of the MIDAS domain in Mdn1. 
Therefore, I propose to introduce HaloTag and SNAP tag to the N- and C-
terminus of the full-length Mdn1 and then label them with different 
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fluorophores that are appropriate for the FRET assays. The kinetics of 
intramolecular docking of MIDAS domain on the AAA ring can then be 
analyzed by single-molecule FRET assay. In addition, similar experiments can 
be performed using E1637Q-Mdn1 and the comparisons between the results 
of wild-type and mutant Mdn1 will reveal how hydrolysis in AAA5 ATPase site 
contribute to the intramolecular docking of the MIDAS domain. These studies 
will reveal the kinetic aspects of the mechanochemical cycle of Mdn1 and also 






Targeting pathogenic fungi using Rbin analogs 
Note to readers: the results discussed below arose from a collaborative effort 
between myself and several colleagues in the Kapoor Lab at The Rockefeller 
University and the Tri-institutional Therapeutics Discovery Institute. With the 
permission of Prof. Kapoor, I have included studies I contributed and noted 
other persons’ contribution to specific data in the Figure legends. 
Appendix 2.1 Introduction 
Invasive fungal infections are important causes of morbidity and 
mortality (Roemer and Krysan, 2014). In particular, the increasing number of 
patients affected by HIV/AIDS, primary immune deficiency and cancer 
chemotherapy, dictates a larger pool of vulnerable patients for pathogenic 
fungi. On the other hand, there are currently only three classes of antifungal 
drugs approved by FDA: azoles, polyenes and echinocandins (Roemer and 
Krysan, 2014). The emerging drug-resistant pathogenic fungi strains also 
highlight the unmet medical needs for the development of new therapeutic 
reagents. 
Our studies on Rbin analogs suggest that these cell-permeable 
compounds potently inhibit the growth of fission yeast by blocking the 
ribosome biogenesis, an essential process that has not been targeted before. 
Here, we aimed to optimize the chemical inhibitor by screening a broader 
range of Rbin analogs for a proof of concept study of using ribosome 
biogenesis inhibitor as antifungal reagents. 
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Appendix 2.2 Results 
We first aimed to optimize Rbins’ potency and potential 
pharmacological properties. Twenty compounds were designed and 
synthesized to analyze the Structure-Activity-Relationship of the derivatives 
based on the tri-cyclic triazinoindole scaffold (Appendix Figures 2-1A to C). 
Fixed doses (10, 1 and 0.1 μM) of compounds were tested in the fission 
growth assay in liquid culture (Appendix Figure 2-1D) and dose-dependent 
inhibition curves were analyzed to determine the potency of the active analogs 
(Appendix Figures 2-1A, B and E). We discovered that addition of a single 
methyl group at the A ring of Rbin-1 results in substantial fluctuations of 
potency, from ~20 fold more potent for the 7-methyl analog (Rbin-4469, GI50= 
7 ± 2 nM, n=6, mean ± SD) to ~2 fold less potent for the 6-methyl analog 
(Rbin-4481, GI50=240 ± 80 nM, n=6, mean ± SD) when compared to Rbin-1 
(reported GI50=136 ± 7 nM, n=6, mean ± SD). These results, along with the 
previous data showing that addition of bromine or iodine substitution on the A 
ring dramatically change the potency of the analogs, are consistent with a 
hypothesis that the A ring is close to a well-defined pocket when Rbin analogs 
bind to their cellular target, so that activities of Rbin analogs in fission yeast 
are greatly affected by various modifications. 
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Appendix Figure 2-1. Structure-activity relationship of Rbin derivatives in 
S. pombe. (A-C) Twenty Rbin derivatives are grouped as (A) variations of A 
ring and thiol linkage, (B) variations of thiol substituents and (C) variations of 
the triazinoindole ring. Fixed doses of Rbin analogs were mixed with wild-type 
S. pombe cells and kept growing at 29 °C for 18 hours. Half maximum growth 
inhibition for active compounds (GI50, mean ± SD, n = 6, two independent 
experiments) are summarized in (A) and (B). The corresponding data are 
shown in (D) for screening or (E) for dose-response curves. The GI50 is 
determined by fitting relative growth to a four-parameter sigmoidal dose-
response curve in PRISM (dose-response curves and GI50 values of wild-type 
S. pombe strain (black) or the mutant strain carrying L1113F mutation in Mdn1 
that is more sensitive to Rbin-1/Rbin-2 inhibition, mean ± SD, n = 6, two 
independent experiments). (F) Comparisons of growth inhibition of wild-type S. 
pombe strain and the mutant strain carrying E1187K mutation in Mdn1 that is 
more resistant to Rbin-1/Rbin-2 inhibition by the Rbin analogs at 1 µM (mean ± 
SD, n = 6, two independent experiments). Note: The compounds were 
provided by Tri-Institutional Therapeutic Discovery Institute. The experiments 
on analyzing the compound activities are performed by myself and Ashley C. 




We next focused on addressing the potential liability of the sulfur 
linkage in the Rbin scaffold as oxidation of the sulfur ether to sulfoxide or 
sulfone can potentially make this substituent a good leaving group for aromatic 
nucleophilic substitution. Briefly, we discovered that substitution of the sulfur 
ether linker by a secondary amine linker ‘NH’ almost completely abolished the 
effect of growth inhibition in yeast (Rbin-4541 and Rbin-4686). On the other 
hand, the analogs with oxygen ether linker with isobutene substituent retain 
the potency (GI50: 1.1 ± 0.3 μM (Rbin-4839); 0.47 ± 0.7 μM (Rbin-4542); n=6, 
mean ± SD).  
We also tried to change the sulfur substituents based on the 7-methyl 
analog in order to avoid potential oxidation of the unsaturated double bond 
and reduce the hydrophobicity of Rbin-1 (Appendix Figure 2-1B). Saturated 
alkyl chain or ring analogs possess weakened activities in the growth assay. In 
addition, analogs with more hydrophilic groups, such as difluoro cyclohexane 
and tetrahydrofuran (THF), are all potent inhibitors of yeast growth (GI50< 0.2 
μM). These results suggest the thiol substituents can be either hydrophobic or 
hydrophilic for active Rbin analogs. 
Analogs with modifications of the tricyclic core (triazinoindole) in Rbin-1 
were also synthesized and tested in the growth assays (Appendix Figures 2-
1C and D). In particular, two analogs with one fewer nitrogen atoms in the 
triazine ring abolished the activities (Rbin-6127 and Rbin-6206). Breakdown of 
the central five-membered ring (B ring as labeled in Appendix Figure 2-1A) 
also gave rise to inactive compounds (Rbin-6139). Adding a methyl group to 
the indole nitrogen on an active compound, Rbin-2 (reported in 2.3 Results), 
also leads to inactive compound (Rbin-4133). In sum, the SAR analysis of 
Rbin-1 analogs suggests that activities of Rbin in fission yeast require the 
143 
tricyclic triazinoindole core while the A ring and thiol substituents are 
amenable to changes. We also analyzed the effect of these twenty 
compounds on the growth of S. cerevisiae, another widely used model fungi 
organism in laboratories. Most compounds are not active against budding 
yeast except Rbin-4483 (GI50: 10 ± 1 μM). 
Appendix Figure 2-2. Structure-activity relationship of Rbin analogs in S. 
cerevisiae. (A) S. cerevisiae cells with deleted efflux pumps were incubated 
with Rbin analogs (10 μM) and kept growing at 29 °C for 18 hours. The 
relative OD600 values of cultures with compounds to cultures with DMSO are 
plotted (mean ± SD, n = 4, two independent experiments). (B) Half maximum 
growth inhibition for Rbin-4483 was determined by fitting relative growth to a 
four-parameter sigmoidal dose-response curve in PRISM (GI50= 10 ± 1 μM, 
mean ± SD, n = 6, two independent experiments). (Note: The experiments on 
analyzing the compound activities are performed by Ashley Wang, a research 
assistant in the Kapoor laboratory). 
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Activities of the lead compound, Rbin-1 and four different chemotypes 
were further examined in the following studies: 1) Rbin-4469, which is the 
most potent compound in fission yeast; 2) Rbin-4542, which has an oxygen 
ether linker and a benzyl substituent; 3) Rbin-5032, which has a more 
hydrophilic THF substituent on the sulfur atom; 4) Rbin-5041, which has 
saturated isobutyl substituent on the sulfur atom.  
First, I analyzed the toxicities of Rbin-1 and the four representative 
chemotypes in HCT116 cell line, a human colon cancer cell line (Appendix 
Figure 2-3). At 10 μM, all five compounds did not affect the growth of the 
human cell line compared to DMSO control (final DMSO: 1%), suggesting 
these compounds can potentially be used as anti-fungi reagents in 
mammalians.  
The potential antifungal activities of the four representative chemotypes 
were then tested in a variety of pathogenic fungi including Candida 
parapsilosis, Candida krusei, Candida albicans, Candida glabrata, 
Cryptococcus neoformans, Aspergillus fumigatus, Paecilomyces variotii, 
Fusarium sp., Rhizopus arrhizus, Scedosporium, Coccidioides sp. and 
Histoplasma capsulatum. Interestingly, Rbin-4469 has MIC values <0.03 
μg/mL and <0.25 μg/mL of against Coccidioides sp. and Histoplasma 
capsulatum according to liquid culture growth assays (Data done by others). 
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Appendix Figure 2-3. Toxicities of Rbin analogs in HCT116 cell line. (A) S. 
cerevisiae cells with deleted efflux pumps were incubated with Rbin analogs 
(10 μM) and kept growing at 29 °C for 18 hours. The relative OD600 values of 
cultures with compounds to cultures with DMSO are plotted (mean ± SD, n = 
4, two independent experiments). (B) Half maximum growth inhibition for Rbin-
4483 was determined by fitting relative growth to a four-parameter sigmoidal 
dose-response curve in PRISM (GI50= 10 ± 1 μM, mean ± SD, n = 6, two 
independent experiments).  
Appendix 2.3 Discussion 
Our results suggesting activities of Rbin derivatives in S. pombe can be 
tuned by making different modifications in the substituents of the tri-cyclic 
triazinoindole core but not the core itself, suggesting the heteroatoms in the 
core are required to interact with their protein targets. 
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The lack of activities of Rbin derivatives in S. cerevisiae and human 
cells may result from th`e differences between S. cerevisiae and H. sapiens 
and S. pombe Mdn1 or difference in compound metabolism or efflux pumps in 
these different organisms. 
The activities of Rbin-4469 against only Coccidiodies and Histoplasma 
cells are interesting as these two organisms are closely related in the 
phylogenic tree of fungi. Experiments using mouse model for Coccidiodies or 
Histoplasma infection are currently undergoing to investigate whether Rbin 
analogs indeed can be used to suppress the pathogenic fungi in vivo. 
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APPENDIX 4 
EM processing of AMPPNP-Mdn1 and Mdn1-ΔC 
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Appendix Figure 4-1. Processing of the Cryo-EM data for full-length 
Mdn1 in the presence of AMPPNP. (A) A cryo-EM image of AMPPNP-Mdn1 
processed with MotionCor2. Some Mdn1 particles are marked (white circles). 
Scale bar: 20 nm. (B) The workflow used to process the pilot dataset. 3D 
classification revealed structural variability due to movement around a hinge 
point (red arrows). After refinement of the class showing the most structural 
detail, the final map was used to generate masks for the entire elongated 
molecule, as well as for the AAA ring region (N-terminal of the hinge point) and 
tail region alone (C-terminal of the hinge point). The density map was also 
used as the initial reference for processing the complete dataset. (C) The 
workflow used to process the complete dataset. The angular distributions of 
the particles in the final reconstructions are shown next to the corresponding 
maps. Note: the resolution of the final reconstruction is further discussed in 
Appendix Figure 4-2A. 
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Appendix Figure 4-2. Cryo-EM analysis of full-length Mdn1 in the 
presence of AMPPNP. (A) Gold-standard Fourier Shell Correlation (FSC) 
curves calculated between independently refined half maps (each half map 
was reconstructed using randomly selected 50% of the particles) for the N- 
and C-terminal regions of AMPPNP-Mdn1 relative to the hinge point. For the 
map of the C-terminal density, the resolution was estimated as ~5.9 Å, more 
conservatively than the value suggested by the FSC = 0.143 criterion (~5.3 Å). 
(B) Local-resolution map of the N-terminal density that includes the AAA ring 
calculated by ResMap in RELION 2.0. (C) Representative EM densities are 
shown (grey mesh) for the map of the N-terminal AMPPNP-Mdn1 region, 
together with the built model (green ribbons). The β-carbons are shown for 
selected side chains. (D) The densities corresponding to the nucleotides in 
AAA4 and AAA6 of AMPPNP-Mdn1 are shown (grey mesh), together with the 
modeled AMPPNP molecules (sticks). The β-carbons of the key lysine 
residues in the Walker A motifs in AAA4 of Mdn1 (K1199) and AAA1 of dynein 
(K1882) are shown. The alpha-carbons of residues in the N loops that are 
important for the interaction with the adenine ring of the nucleotides are also 
shown. For comparison, the box to the right shows ADP bound to AAA1 in D. 
discoideum dynein (PDB: 3VKG) (Kon et al., 2012). (E) Validation of the model 
for the N-terminal ring region of AMPPNP-Mdn1 (as also shown in Figure 4-
1C) by cross-validation FSC curves: “work” (blue curve), refined model versus 
half map 1 used for refinement (work map); “free” (red curve), refined model 
versus half map 2 that was not used for refinement (free map); “combined” 
(black), refined model versus the combined final map. The similarity of the 
“work” and “free” curves suggests no substantial over-fitting. (F) Local-
resolution map of the density of the C-terminal tail region of AMPPNP-Mdn1 
calculated by ResMap in RELION 2.0. 
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Appendix Figure 4-3. Cryo-EM analysis of Mdn1-ΔC in the presence of 
AMPPNP. (A) Schematic of the Mdn1-ΔC construct that lacks the C-terminal 
D/E-rich and MIDAS domains (aa 1-3911). The D/E-rich domain starts at aa 
3912. (B) Size-exclusion chromatography profile for Mdn1-ΔC (elution volume: 
11.5 mL). The elution volumes of the void peak (7.5 mL) and full-length Mdn1 
(Mdn1-FL, 10.6 mL) are also indicated for comparison. (C) Peak fractions from 
the size-exclusion chromatography of Mdn1-ΔC and Mdn1-FL were analyzed 
by SDS-PAGE (Coomassie blue stain). (D) A cryo-EM image of AMPPNP-
Mdn1-ΔC processed with MotionCor2. Some Mdn1-ΔC particles are marked 
(white circles). Contaminant particles are also marked (red circles). Scale bar: 
20 nm. (E) Workflow used to process the dataset. Classes representing 
contaminant particles (red circles) were removed from the dataset. The 
angular distributions of the particles in the final reconstructions are shown next 
to the corresponding maps. Note: the resolution of the final reconstructions is 
further discussed in (F). (F) Gold-standard FSC curve calculated between 
independently refined half maps for the N- and C-terminal regions of 
AMPPNP-Mdn1-ΔC. For the map of the N-terminal density, the resolution was 
estimated as ~6.5 Å, more conservatively than the value suggested by the 
FSC = 0.143 criterion (~6.1 Å). (G) Local-resolution maps for the N- and C-
terminal regions of Mdn1-ΔC calculated by ResMap in RELION 2.0. (H) Two 
views of the EM density map of Mdn1-ΔC (yellow surface). The Mdn1 model 
for full-length Mdn1 (ribbons, colored blue and purple for the AAA ring and 
hook-shaped tail regions, respectively) could be placed into the Mdn1-ΔC map 




EM processing of ATPI-Mdn1 
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Appendix Figure 5-1 Cryo-EM analysis of Mdn1 in the presence of ATP 
and Rbin-1. (A) A cryo-EM image of ATPI-Mdn1 processed with MotionCor2. 
Some Mdn1 particles are marked with white circles. Scale bar: 20 nm. (B) The 
workflow used to process the pilot dataset. (C) The workflow used to process 
the complete dataset. The angular distribution of the particles in the final 
reconstruction is shown next to the final map. (D) Gold-standard FSC curve 
calculated between independently refined half maps for ATPI-Mdn1. The 
resolution was estimated as ~7.7 Å (FSC = 0.143). (E) Local-resolution map 
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